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I 
Abstract 
 Oxidative stress and inflammation are two reciprocally linked processes that 
characterise many disease states, but can also transiently increase in response to a range of 
stimuli, including exercise, to initiate adaptation. This thesis presents novel data indicating 
that oxidative stress did not increase in response to an acute mental arithmetic challenge, 
under resting conditions or experimentally induced high baseline inflammation. In the context 
of exercise, chapters 3, 4 and 5 support previous work that markers of plasma and peripheral 
blood mononuclear cell (PBMC) oxidative stress increase in response to acute exercise. 
Acute exercise (30-40 min, 70% VO2MAX) in rheumatoid arthritis patients caused a transient 
increase in protein carbonylation that over a period of training (3 months, 3 sessions per week) 
at the same intensity did not increase global oxidative stress or inflammation. Plasma 3-
nitrotyrosine decreased with exercise training, alongside improvements in disease activity 
and aerobic fitness. The last two experimental chapters of this thesis explored acute changes 
in plasma (Chapter 4) and PBMC (Chapter 5) oxidative stress in response to bouts of low 
volume high intensity interval training (LV-HIIT) and steady state exercise (60% maximal 
oxygen consumption (VO2MAX), 27 minutes and 80% VO2MAX, 20 minutes). LV-HIIT 
provided an anti-inflammatory (IL-6 and IL-10) and anti-oxidant (plasma total antioxidant 
capacity and PBMC thioredoxin protein content) response to exercise that paralleled the 
response (magnitude and timecourse) observed with steady state exercise of high and 
moderate intensity. 
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1. General Introduction 
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1.1. Summary 
Oxidative stress (Harman, 2006; Seven et al., 2008) and inflammation (Singh and 
Newman, 2010; Libby, 2008) are two processes that impact upon health, fitness, ageing and 
disease. Acute increases in exercise-induced oxidative stress and inflammation have been 
linked with post-exercise adaptations (Gomez-Cabrera et al., 2008; Gleeson et al., 2011). 
Furthermore, evidence suggests a reciprocal relationship between oxidative stress and 
inflammation, whereby each process may initiate and progress the other (Wadley et al., 2013). 
The aims of this thesis were to assess oxidative stress and inflammation in response to 
various stimuli, with a primary focus on exploring and characterising the responses to 
exercise. Studies were designed to investigate potential links between oxidative stress and 
inflammation (Zhou et al., 2010; Riddell et al., 2010; Fu et al., 2002), mostly in the context of 
exercise. 
 
1.2. Oxidative Stress 
1.2.1. Overview 
Reactive Oxygen and Nitrogen species (ROS and RNS, collectively RONS) are 
highly reactive natural derivatives of cellular oxidation processes, that are almost always 
characterised by the presence of one or more unpaired electrons in their outer shells (i.e. free 
radical species). RONS are produced from an array of environmental (i.e. radiation and 
inorganic particles) (Martin et al., 1996) and biological (endogenous oxidase enzymes, 
electron transport chain and peroxisomes) sources (Brandes et al., 2010) and are key in the 
regulation of normal biological processes such as cellular respiration and signalling (Apel and 
Hirt, 2004). The reduction of molecular oxygen to form superoxide (O2-.) is central (directly 
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or indirectly) in the formation of other RONS such as peroxynitrite (ONOO-), lipid peroxyl 
(LOO.) and hydroxyl radicals (OH.).   
Antioxidants are a counterbalance to the reactivity of RONS that function by directly 
‘quenching’ RONS or indirectly, by reducing oxidised substrates (Nordberg and Arner, 2001) 
and stimulating the transcription of other antioxidant systems (Burke-Gaffney et al., 2005). In 
situations where antioxidant defences can effectively regulate the levels of RONS, the net 
effect is the promotion of adaptive physiological responses, such as increased expression of 
protective antioxidant enzymes and stress proteins (Ji, 2001). This response helps to maintain 
redox balance and preserve free cellular thiols (Jacob and Ba, 2011). Conversely, a 
substantial pro-oxidant shift in the balance between RONS and antioxidants can facilitate 
adduct formation on proteins, lipids and DNA. This situation is termed ‘oxidative stress’ and 
is associated with the ageing process (Harman, 1956) and many disease pathologies (Seven et 
al., 2008; Butterfield et al., 2006; Dhalla et al., 2000; Ceriello and Motz, 2004). 
Due to the transient nature of RONS, it is common practice to measure the formation 
of adducts (Harman, 2006), which may act as ‘‘footprints’’ of RONS-mediated reactions.  
Care must be taken when interpreting results employing these methods, as markers of 
oxidative stress are not direct measures of RONS production. However, markers of 
biomolecule oxidation/nitration are routinely measured in biomedical research and are widely 
accepted as reflective markers of oxidative stress. 
 
1.2.2. Protein Oxidation 
 The backbone of a protein polypeptide chain is highly susceptible to reaction with 
RONS (Stadtman and Berlett, 1997). Certain amino acids (i.e. histidine, arginine and lysine) 
contain redox active sulphur-hydryl (-SH) groups, also called thiol groups that similarly to 
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some RONS contain unpaired outer shell electrons. As a result, during heightened periods of 
oxidative stress, amino acid side chains can be targeted by RONS such as OH., causing 
oxidative modifications that stabilise outer shell stability of both molecules. Mildly oxidised 
proteins can be reduced by antioxidant systems or degraded and removed by the proteasome 
system (Breusing et al., 2009), however excess protein oxidation can lead to protein 
aggregation and inhibition of cellular and non-cellular processes (Goto et al., 2007). Common 
protein adducts include dityrosine, protein-protein cross linking and protein carbonyl groups. 
Protein carbonyls are the most studied marker of protein oxidation in vivo (Dalle-Donne et al., 
2003; Levine et al., 1994), due to their immunogenic properties and ability to derivatize with 
2, 4-dinitrophenylhydrazine (DNPH) to form a 2,4-dinitrophenyl group (Reznick and Packer, 
1994). This can be easily detected using spectrophotometric assays (Carty et al., 2000) or 
antibody technology (i.e. Enzyme-linked immunosorbent assay (ELISA) (Buss et al., 1997) 
or western blotting (Levine et al., 1994)). 
 
1.2.3. Protein Nitration 
 Protein nitration occurs as part of RNS-mediated signal transduction by secondary 
products of nitric oxide (NO) metabolism, such as peroxynitrite (ONOO-) and nitrogen 
dioxide (NO2.). ONOO- is formed from the reaction between NO and O2-. (Beckman, 1996) 
and outcompetes the removal of O2-. by superoxide dismutase (SD), thus making ONOO- a 
highly prominent radical species (Beckman et al., 1990). ONOO- can nitrate amino acids, 
commonly tyrosine, by adding a nitro group to the benzene ring that forms the adduct 3-
nitrotyrosine (3-NT) (Souza et al., 2008). This conformational change to cellular (Benhar et 
al., 2008, 2010) and non-cellular proteins (Griffiths et al., 2006) can regulate various aspects 
of protein function (Benhar et al., 2008). Examples include tyrosine phosphorylation 
signalling (Kong et al., 1996) and lipoprotein regulation (Griffiths et al., 2006) respectively. 
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3-NT is commonly quantified using high performance liquid chromatography with 
electrochemical detection (EC-HPLC), however ELISA and western blotting are also used 
(Herce-Pagliai et al., 1998). 
 
1.2.4. Lipid Oxidation 
 Cellular and non-cellular polyunsaturated fatty acids (PUFA) are susceptible to 
reaction with RONS (Niki, 2009). Double bonds in PUFA’s (i.e. arachidonic and linoleic 
acids) of phospholipid membranes and plasma lipids (i.e. fatty acyls, glycerolipids, 
glycerophospholipids, sphingolipids, sterols, and prenols (Quehenberger et al., 2010)) and 
low density lipoproteins (LDL) can be targeted by RONS forming stable lipid peroxidation 
(LPO) end products. The abstraction of hydrogen from the methylene group of PUFA’s can 
form a carbon radical that can rearrange to from conjugated dienes, that can be further 
oxidised to form lipid and peroxyl radicals (Buettner, 1993). These highly reactive radical 
species can then propagate a chain reaction whereby multiple LPO products are formed, 
including lipid hydroperoxides (LOOH) and short (malonaldehyde (MDA) and 4-
hydroxynonenal (4-HNE)) and long chain (i.e. F2-isoprostanes) aldehyde products (Niki, 
2009; Buettner, 1993). Increased formation of LPO products can modulate systemic lipid 
metabolism (Fuhrman et al., 1995) and the assembly of cell membranes, altering fluidity, 
permeability and functioning of cellular signalling (Nikolaidis et al., 2011). Quantification of 
LPO products can be achieved through antibody technology (i.e. 4-HNE), mass spectrometry 
(i.e. F2-isoprostanes) and spectrophotometric assays (i.e. LOOH and MDA) (Breusing et al., 
2010). 
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1.2.5. Antioxidants 
Indicators of antioxidant status primarily differ by the function (enzymatic and non-
enzymatic), target (i.e. specific RONS or oxidised molecule), location (i.e. endogenous and 
exogenous) and routine method of quantification (i.e. protein expression, gene expression or 
enzymatic activity) of the antioxidant. Many antioxidants function by mimicking the 
downstream target of a specific RONS, or by reversing/suppressing specific oxidation events 
on proteins, lipids or DNA molecules. An example is the binding of antioxidants to proteins 
and DNA to suppress iron-mediated oxidation (Wiedenheft et al., 2005). Common measures 
of antioxidant capacity include the assessment of the protein expression and activity of 
reduced:oxidised glutathione (GSH:GSSG ratio) and RONS specific antioxidant enzymes 
(SOD and catalase (CAT)). In addition, plasma contains a multitude of soluble antioxidant 
compounds such as vitamins (ascorbic acid and α-tocopherol), albumin bound thiols, 
bilirubin and uric acid that can be collectively assessed using total antioxidant capacity (TAC) 
assays (Cao and Prior, 1998). Finally, the assessment of peroxide scavenging proteins 
thioredoxin (TRX) and peroxiredoxin (PRDX) are emerging as indicators of cellular 
antioxidant status.  
 
1.3. Inflammation 
1.3.1. Overview 
Inflammation is a bodily defence mechanism that is initiated in response to tissue 
damage or infection, mediated by signalling cytokine molecules, and characterised by the 
influx of migrating leukocytes (Medzhitov, 2008). Acute inflammation is a transient, adaptive 
response leading to transcriptional activation of multiple anti-inflammatory cytokines, 
whereas chronic inflammation is characterised by an ‘‘overdrive’’ of inflammatory mediators, 
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progressing to increased levels of systemic inflammation (Stevens et al., 2005). Increased 
levels of systemic inflammation are implicated in many disease states, notably dementia 
(Engelhart et al., 2004), rheumatoid arthritis (Lee and Weinblatt, 2001), and cardiovascular 
disease (Tracy, 1998). Indeed C-reactive protein (CRP), a marker of systemic inflammation, 
is present within most atherosclerotic plaques and is implicated in the pathogenesis, 
progression and complications of cardiovascular disease (Devaraj et al., 2009). 
The inflammatory response (figure 1.1) is initiated by a rapid infiltration of 
leukocytes to the site of infection, which then engulf the invading pathogen. During this 
response neutrophils weakly adhere to the blood vessel wall via cellular adhesion molecules 
(CAMS), that can initiate a rolling motion (Mayrovitz et al., 1977). The release of neutrophils 
to the site of infection is then mediated by a chemotactic gradient across the endothelial wall. 
Interleukin (IL)-1β has been identified as the chemokine involved in this initial inflammatory 
process, alongside IL-8, which directly recruits neutrophils to the site of tissue damage 
(Utgaard et al., 1998). Another cytokine, IL-6, then recruits monocytes into blood vessels, 
instigating the differentiation of monocytes into pathogen-disposing macrophages (Kaplanski 
et al., 2003). Additionally, Tumour Necrosis Factor-alpha (TNF-α) is involved in the 
recruitment of CAMS to the endothelial wall (Willerson and Ridker, 2004; Bruunsgaard, 
2005). 
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Figure 1.1: Typical Inflammatory Response. Blood leukocytes can travel to the site of 
tissue damage through the actions of cytokine molecules that mediate cellular recruitment 
(IL-1β, IL-8) adhesion (TNF-α), and differentiation (IL-6). These cytokine mediators allow 
specific leukocyte cell types to dispose of the inflammatory stimulus. CAMS = cellular 
adhesion molecule, ° denotes cytokine molecule (specific cytokines are indicated in bold 
where appropriate). All cell types in the above example are neutrophils unless stated. Figure 
adapted from Wadley et al, 2012, American Association of Aging. 
 
1.3.2. Markers of Inflammation 
 The inflammatory response is characterised by a large shift in the production, 
mobilisation and distribution of leukocytes to an ‘injured’ area of the body (i.e. pathogen, 
tissue damage or pollutant). Shifts in the subsets of leukocytes can be measured using 
automated cell counters (Cox et al., 1985) or microscopy using Wright’s reagent staining 
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(Stain et al., 2013). Cytokine molecules are small polypeptides released either locally 
(autocrine and panacrine) or systemically (endocrine) from leukocytes to mobilise further 
leukocyte sub sets as well as signalling to cellular kinases to regulate the activity and 
transcription of adaptive proteins (Febbraio et al., 2010). Many cytokines facilitate the 
inflammatory process and the relevance for each marker to the separate studies will be 
detailed in each chapter. Briefly, interleukin (IL-) 1β, IL-8, IL-6 and TNF-α cytokines are 
involved in the acute phase response (Gabay and Kushner, 1999) and are easily measured 
using sandwich ELISA techniques. Additionally, cytokines are known to stimulate the release 
of acute phase proteins such as CRP, serum amyloid A, complement proteins and fibrinogen 
from the liver (Stevens et al., 2005; Gabay and Kushner, 1999). These can all be measured as 
indicators of systemic inflammation. 
 
1.4. Nitric Oxide 
Nitric oxide (NO) is a radical species with diverse biological properties. NO Synthase 
(NOS) is the key regulatory enzyme in the synthesis of NO, comprising endothelial (eNOS), 
inducible (iNOS) and neuronal (nNOS) isoforms. Further, recent evidence has demonstrated 
that NO can be synthesised through dietary nitrate (NO3-) intake (Benjamin et al, 1994). 
Anaerobic bacteria in the enterosalivary circulation can reduce dietary NO3- to nitrite (NO2-), 
which can be absorbed into the systemic circulation and reduced by various enzymes 
(xanthine oxidase and carbonic anhydrase) and reducing agents (ascorbate and polyphenols) 
to form NO under hypoxic conditions (Bailey et al, 2012). In small amounts NO can govern 
cellular growth and proliferation (Guzik et al., 2003) through regulation of cellular kinase 
activity, immune function and blood flow distribution via the dilation of smooth muscle cells 
(Lundberg and Weitzberg, 2009). Conversely, inflammation driven NO production is 
typically a much larger and sustained response that far surpasses the physiological amounts 
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required to govern NO related signalling and adaptation (Kim et al., 1999). As a result, NO 
produced via iNOS is typically linked with cellular arrest and apoptosis (Parratt, 1997).   
NO is a transient molecule, due to its rapid oxidation in vivo (Beckman et al., 1990)  
and is therefore very difficult to directly monitor in blood or urine. A number of different 
measures have been used to try to assess NO availability. Traditional indirect methods 
involve functional assessments of NO-related vasomotion in response to physiological and/or 
pharmacological stimuli that block the actions of NO-mediated blood vessel dilation to test 
NO availability. Additionally, circulatory markers of NO metabolism, nitrite (NO2-) and 
nitrate (NO3-) are routinely assessed in plasma and urine as indicators of NO availability 
(Moshage et al., 1995). Given that dietary nitrate can largely influence NO metabolism and 
thus plasma NO2- and NO3-, strict dietary control is typically implemented in these studies. 
Quantification of NO2- can be achieved using a luminescent assay based technique (Moshage 
et al., 1995). 
 
1.5. Oxidative Stress & Inflammation – Interactions and Similarities 
1.5.1. Overview 
Oxidative stress and pro-inflammatory processes are often deemed to be mutually 
dependent, with studies suggesting that oxidative stress is a direct stimulus for inflammation 
and vice versa (Kim et al., 2006). It has been established in vitro that neutrophils present 
during an inflammatory response may directly produce ROS, such as O2-. (Babior et al., 
1973). In addition, RONS (Gloire et al., 2006) and inflammatory cytokines (Donato et al., 
2009) have both been shown to stimulate the redox-sensitive transcription factor NF-ĸB, and 
although NF-ĸB is a relatively non-specific transcription factor this does link oxidative stress 
and inflammation with a common integrative source (figure 1.2). Furthermore, the oxidation 
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of mitogen activated protein kinase (MAPK) (i.e. kinase/phosphatase balance) (Naik and 
Dixit, 2011; Choi et al., 2002), an upstream regulator of NF-ĸB, may directly and indirectly 
modulate inflammation respectively. Despite these documented links, novel protein markers 
appear to provide further upstream links between oxidative stress and inflammation. 
Inflammatory proteins such as α-1-antitrypsin, α-1-proteinase inhibitor, α-1-antiproteinase 
(Choi et al., 2002) and complement protein 4 (Hart et al., 2004) are all susceptible to 
oxidation, which may enhance inflammation (Kalsheker, 1994; Moraga, 2000). The roles of 
IL-8 and the redox proteins TRX and PRDX are primary focus of this thesis and may provide 
mechanistic links between oxidative stress and inflammation. 
 
Figure 1.2:   Activation of NF-ĸB by reactive oxygen species and inflammatory 
cytokines. NF-ĸB is constitutively expressed in the cytosol of cells, bound to inhibitory-
 
 
 
 
 
Pro-inflammatory 
transcription 
IKK 
IkB-α 
Cytosol 
Nucleus 
Inflammatory Cytokines RONS 
NF-kB 
P65 
P50 
NF-kB 
Proteosomal 
Degradation 
Oxidative stress & 
Inflammation 
P50 P65  
 
 
 
12 
 
kappa B Kinase (IKK). RONS and inflammatory cytokines can activate IKK to preferentially 
phosphorylate specific sub-units of NF-ĸB to initiate migration into the nucleus for pro-
inflammatory transcription.   
 
1.5.2. Interleukin-8 as a link between oxidative stress and inflammation 
IL-8 has been suggested to be a link between oxidative stress and inflammation, via 
the metabolism of prostaglandins. Prostaglandins are compounds derived from fatty acids that 
regulate cellular growth and differentiation near the site of their release (Smith, 1989). It has 
been proposed that 15-Deoxy-Delta-12,14-prostaglandin J2 may directly modify components 
of the electron transport chain and potentiate radical leakage (Kondo et al., 2001). Evidence 
suggests that radicals may then signal via MAPK to directly upregulate the expression of IL-8 
cytokines (Fu et al., 2002). IL-8 is a cytokine known to recruit neutrophils at the beginning of 
the inflammatory response (Utgaard et al., 1998), which may initiate a respiratory burst 
(Babior et al., 1973), thus providing a full cyclic link between IL-8 and oxidative stress. 
 
1.5.3. Thioredoxin 
TRX is a ubiquitous oxidoreductase protein present within the cytoplasm, nuclei and 
mitochondria of cells (Go et al., 2007). TRX can exist in a reduced or oxidised state, 
dependent on the level of systemic oxidative stress and availability of redox sensitive thiol 
groups. When in a reduced state, TRX can act as an antioxidant, utilising its thiol group to 
directly scavenge ROS, as well as activating the expression of various antioxidant enzymes 
(Burke-Gaffney et al., 2005) and regenerating GSH (Tan et al., 2010) and vitamin C (May et 
al., 1997). In its oxidised form, TRX forms an intra-molecular disulphide bridge that blocks 
antioxidant function. Recent evidence has implicated a TRX binding protein, Thioredoxin-
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interacting protein (TXNIP), as a link between elevated oxidative stress and inflammation 
(Zhou et al., 2010; World et al., 2011; Lane et al., 2013) (figure 1.3). TXNIP can bind to 
TRX via a disulphide bond, inhibiting TRX antioxidant function (Patwari et al., 2006). An 
increase in ROS has been shown to promote dissociation of TXNIP from TRX, enabling 
TRX to scavenge ROS, whilst TXNIP activates the NLP3 inflammasome to produce the 
inflammatory cytokine, IL-1β (Zhou et al., 2010). IL-1β is implicated with the activation of 
various other cytokines and evidence has drawn associations between TRX-TXNIP with IL-
1α, IL-6, IL-8, TNF-α and IL-2 production (Yamada et al., 2003; Schenk et al., 1996). It 
therefore appears that despite the antioxidant properties of TRX, TXNIP can indirectly 
enhance the inflammatory signal during periods of heightened oxidative stress. Indeed, there 
is some evidence implicating elevated TXNIP protein expression with metabolic (Zhou et al., 
2010) and cardiovascular (Schulze et al., 2006) pathology. 
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Figure 1.3:   Schematic of the TRX redox cycle. TXNIP can form a disulphide bond with 
the active site of TRX, blocking TRX antioxidant function. Unbound TXNIP is associated 
with heightened inflammatory cytokine production.  
 
1.5.4. Peroxiredoxin 
PRDX are a family of oxidoreductase proteins containing thiol groups with a high 
capacity to control cellular levels of RONS and reduce oxidative stress (Schenk et al., 1994; 
Wood et al., 2003). PRDX can exist in a series of oxidation states that allows the enzyme to 
directly target and reduce biological peroxides such as hydrogen peroxide (H2O2), ONOO-
 and LOOH (Wood et al., 2003) (figure 1.4). Further, this allows PRDX to regulate peroxide 
mediated-signalling, primarily within lipid rafts of cells (Rhee et al., 2012). Recent work has 
highlighted the role of PRDX in modulating inflammation and immune function (Riddell et 
al., 2010). PRDX appears to have intra and extra-cellular functions that may protect against 
infection, cell death and cancer (Ishii et al., 2012). Work in isolated macrophages and 
dendritic cells has indicated that PRDX can bind to toll-like receptor-4 (TLR-4) and stimulate 
the production of inflammatory cytokines such as TNF-α and IL-6, via NF-ĸB (Riddell et al., 
2010). It therefore appears that PRDX may provide a novel link between oxidative stress and 
inflammatory processes. Additionally, TRX reductase appears to provide a link between TRX 
and PRDX redox protein systems by directly and indirectly facilitating reformation of the 
reduced forms of both proteins (figure 1.4). 
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Figure 1.4:   Schematic of the PRDX redox cycle. Schematic indicates how TRX can 
regulate PRDX oxidation by reversing PRDX thiol oxidation. Under conditions of high or 
prolonged peroxide exposure, PRDX can exceed the regulatory control of TRX and become 
over-oxidised. Over-oxidation of PRDX has been associated with heightened inflammation 
via toll like receptor (TLR) activation. Previously undefined terms: S - - - - S denotes a 
disulphide bond. R represents an R group.
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1.5.5. Summary 
It may be possible that IL-8, TRX and PRDX contribute towards amplifying the 
inflammatory signal under conditions where oxidative stress is enhanced, rather than RONS 
inducing inflammation directly. Additionally, oxidative stress induced damage to cellular 
biomolecules such as proteins, lipids and DNA may well initiate inflammation in response to 
damage (Ungvari et al., 2010). However due to a nature of these studies in predominantly cell 
models, caution must be taken when applying these mechanisms in humans, given their 
complexity in vivo.  
 
1.6. Oxidative Stress & Inflammation in Disease  
Various genetic and environmental factors can contribute towards the development of 
human disease. A range of low (Yudkin, 2007; Gleeson et al., 2011) and high grade (Libby, 
2008) inflammatory diseases such as cardiovascular disease (CVD) and rheumatoid arthritis 
(RA) respectively are characterised by increased levels of inflammatory proteins (IL-1β, 
TNF-α, IL-6 and CRP). Further, CVD (Dhalla et al., 2000; Ceriello and Motz, 2004; Cai and 
Harrison, 2000) and RA (Seven et al., 2008; Taysi et al., 2002; Sarban et al., 2005) are 
associated with elevated levels of oxidative stress. The deleterious effects of oxidative stress 
and inflammation in human disease are specific to each disease state, but commonly involve 
degradation of tissue structure or function via excessive oxidative modification (Mapp et al., 
1995). This may lead to activation of apoptotic pathways or conversely an inhibition, 
resulting in a lack of cell clearance (Szabó-Taylor et al., 2012) which can lead to their 
aggregation and ultimately impaired tissue functionality. For example in CVD this may 
manifest as impaired cardiac cell function (Bains and Shaw, 1997; Butterfield et al., 2006) 
and in RA, the degradation of connective tissue in a joint (Mapp et al., 1995). Interestingly, 
both of these diseases are linked by vascular complications and associations with altered NO 
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metabolism (Griffiths et al., 2006; Metsios et al., 2010; Bennett et al., 2009). This will be an 
underlying theme to the first two experimental chapters of this thesis. Evidence suggests that 
oxidative stress and inflammatory processes seen in human disease may disrupt the chain of 
NO synthesis and function, via ONOO- formation (Pryor and Squadrito, 1995; Beckman and 
Koppenol, 1996), which directly attenuates NO-mediated function. Conversely, high levels of 
inflammation NO production can exacerbate oxidative stress and act toxic to cells (Kim et al., 
1999). To understand the complex roles of NO in health and disease, parallel measures of 
oxidative stress and inflammation must be considered. 
 
1.7. Changes in markers of oxidative stress and inflammation during and following 
exercise 
1.7.1. Overview 
Exercise is beneficial for health, and is known to improve cardiovascular function, 
physical fitness and psychosocial health (Metsios et al., 2008). Regular exercise is associated 
with a reduction in multiple cardiovascular risk factors such as correction lipoprotein profiles, 
lowered fat mass and blood pressure (Shephard and Balady, 1999) as well as improved 
vascular function (Clarkson et al., 1999) and enhanced NO release (Lewis et al., 1999). 
Additionally, there is evidence that systemic inflammation (Colbert et al., 2004; Dekker et al., 
2007; Adamopoulos et al., 2002) and oxidative stress (Donato et al., 2010; Radak et al., 1999; 
Fatouros et al., 2004) are both independently reduced as a result of regular physical exercise.   
 
1.7.2. Acute increases in oxidative stress during and following exercise 
It is now widely accepted that a single bout of exercise is accompanied by a transient 
increase in markers of oxidative stress (Fisher-Wellman and Bloomer, 2009; Michailidis et al., 
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2007). Studies examining the responses to exercise have reported that markers of oxidative 
stress positively correlate with muscle damage (Aoi et al., 2004). However, studies utilising 
antioxidant supplementation have demonstrated that quenching radical release in response to 
exercise can prevent not only muscle damage (Dekkers et al., 1996; Goldfarb et al., 1994), 
but a diverse range of signalling events that ultimately lead to adaptation (Ristow et al., 2009; 
Gomez-Cabrera et al., 2008; Khassaf et al., 2003; Hart et al., 2013). Early studies identified 
that RONS have significant roles in stimulating muscle force production (Andrade et al., 
1998), enzyme release (Jackson et al., 1983, 2004) and the transcriptional regulation of 
critical cellular proteins, such as heat shock proteins (Salo et al., 1991) and antioxidant 
enzymes (Khassaf et al., 2003). In addition, recent findings have reported that RONS may 
regulate improvements in insulin sensitivity (Ristow et al., 2009), mitochondrial biogenesis 
(Ristow et al., 2009) and endurance capacity (Gomez-Cabrera et al., 2008). Interestingly, 
antioxidant supplementation has also been shown to suppress the anti-inflammatory response 
to exercise, by reducing muscle derived IL-6 production (Fischer et al., 2004; 
Vassilakopoulos et al., 2003). This underpins the links between oxidative stress and 
inflammation, specifically in the context of exercise.  
 
1.7.3. Measuring exercise-induced oxidative stress: beyond the muscle 
It is well established that activated skeletal muscle is a prominent source of RONS 
during and following exercise (McArdle et al., 2001, 2005; Davies et al., 1982) (figure 1.5). 
O2-. is produced from a range cellular sources within skeletal muscle, notably the 
mitochondria, peroxisomes and via enzymes such as nicotinamide adenine dinucleotide 
(NAD) oxidases, xanthine oxidase, eNOS and nNOS (Powers and Jackson, 2008; Jackson, 
2005). Muscle cells can also release radicals into the extracellular space via enzymes 
expressed on the plasma membrane of the cell (McArdle et al., 2001; Balon and Nadler, 1994; 
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O’Neill et al., 1996). Furthermore, radicals may be produced by cells surrounding and 
infiltrating skeletal muscle, such as endothelial cells (Li and Shah, 2004) and many subsets of 
leukocytes (Babior, 2000) in a controlled and regulated manner (Jackson, 2008). As a result 
markers of exercise-induced oxidative stress are routinely measured in the systemic 
circulation (Goldfarb et al., 2005; Bloomer et al., 2005; Turner et al., 2011b).  
 
Figure 1.5:  Sources of RONS in skeletal muscle. Diagram adapted from Jackson (2000). 
The figure indicates the various enzymatic sources of RONS within and around skeletal 
muscle during exercise. Previously undefined terms: GPx: glutathione peroxidase, Fe3+: ferric 
ion, Ca2+: calcium ion, CuZnSOD: copper-zinc superoxide dismutase, MnSOD: manganese 
superoxide dismutase. 
 
1.7.4. Measuring exercise-induced oxidative stress in plasma 
There is very well documented evidence that plasma markers of oxidative stress are 
increased in response to exercise in humans (Turner et al., 2011b; Bloomer et al., 2007; 
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Goldfarb et al., 2002). Importantly, some studies have reported associations between the 
magnitude of change in oxidative stress in muscle cells and plasma (You et al., 2005; 
Nikolaidis et al., 2008). The systemic circulation plays an integral role in maintaining redox 
balance between tissues (Vollaard et al., 2005). In addition, due to the ease sample collection 
and isolation, plasma measures of oxidative stress are a less invasive alternative to collecting 
muscle biopsy samples and isolating cells. Typical measures of exercise-induced oxidative 
stress include protein carbonyls (Bloomer et al., 2007; Turner et al., 2011c), LOOH (Turner 
et al., 2011b) and indicators of TAC (Turner et al., 2011c; Berzosa et al., 2011). Whist 
alterations in plasma oxidative stress do not reflect oxidative events within muscle that 
directly stimulate adaptation, monitoring exercise-induced changes to plasma markers of 
oxidative stress indicate global perturbations that reflect a wide variety of tissues and 
peripheral cells. Monitoring these changes therefore reflects whole body oxidative 
modifications. 
 
1.7.5. Measuring exercise-induced PBMC oxidative stress  
Exercise-induced oxidative stress is routinely measured in peripheral blood 
mononuclear cells (PBMCs). PBMCs are composed of lymphocytes (≈ 90%) and monocytes 
(≈ 10%) and are a ‘site’ for oxidative modification (Tauler et al., 2006; Sureda et al., 2005) 
and are a source of ROS during exercise (Sureda et al., 2009). Changes in PBMC adducts 
represent a more specific indicator of oxidative stress in response to exercise compared to 
plasma or whole blood, incorporating changes that reflect cellular redox balance and 
oxidative modifications that impact upon immune function. At rest, PBMCs weakly adhere to 
the blood vessel wall via CAMS (Albelda et al., 1994). In response to exercise, increases in 
systemic adrenaline concentrations and exercise-induced shear stress can mobilise PBMCs 
off the blood vessel wall by activating β2-adrenergic receptors (Dimitrov et al., 2009) that 
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weaken CAMS binding and mechanical dislodgement of PBMCs (Shephard, 2003) 
respectively. In addition, PBMCs may infiltrate the contracting skeletal muscle via immune 
regulation of leukocytes to the stressed muscle tissue. Collectively, lymphocytosis is 
observed during and immediately following exercise as PBMC frequency rapidly increases in 
peripheral blood by both mobilisation and recruitment based mechanisms (Turner et al., 
2011a). An array of studies have reported increases in markers of protein carbonylation 
(Turner et al., 2011b), lipid oxidation (Sureda et al., 2005) and antioxidant enzyme systems 
(Sureda et al., 2005; Tauler et al., 2006) following exercise in PBMCs. 
 
1.7.6. Acute increases in inflammation during and following exercise 
 Exercise is accompanied by an acute rise in both skeletal muscle (Akerstrom et al., 
2005; Steensberg et al., 2000) and systemic inflammation (Febbraio et al., 2004; Ostrowski et 
al., 2001). An increase in inflammatory markers is known to be an immunological response 
to muscle ‘stress’ as well as a signalling response for metabolic and transcriptional (i.e. NF-
ĸB) regulation (Pierce et al., 2009). Inflammatory cytokines are released from multiple cell 
types during exercise, notably leukocytes, adipocytes and fibroblasts (Akira et al., 1993). In 
addition, there is accumulating evidence that skeletal muscle can produce muscle-specific 
cytokine mediators known as ‘myokines’ that can regulate substrate metabolism and anti-
inflammatory transcription (Petersen and Pedersen, 2005). Growing attention is focusing on 
the interleukin family of cytokines, specifically IL-6, which is thought to act as an ‘energy 
sensing’ signal to increase hepatic glucose output (Febbraio et al., 2004, 2003) and adipose 
tissue lipolysis (van Hall, 2003) during exercise. In addition, IL-6 is known to control the 
release and transcription of other acute phase proteins such as CRP and anti-inflammatory 
cytokines, IL-10 and IL-1 receptor antagonist (ra) (Tilg et al., 1994; Steensberg et al., 2003) 
respectively. IL-10 can suppress pro-inflammatory cytokine production and activation of pro-
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inflammatory cells, creating an anti-inflammatory environment (Stevens et al., 2005). Over a 
period of exercise training, repeated transient increases of cytokines such as IL-6 and IL-10 
may signal to lower basal inflammation (Dekker et al., 2007; Adamopoulos et al., 2002). 
Mechanisms appear to be primarily: reductions in visceral fat mass (a prominent pro-
inflammatory cytokines source) (Mujumdar et al., 2011), increased anti-inflammatory 
cytokine production (Gleeson et al., 2006), phenotypic cell changes and decreased TLR 
receptor expression (Stewart et al., 2005; Oliveira and Gleeson, 2010). In this manner, 
inflammatory cytokines share a similar acute/chronic relationship to RONS. Given that these 
signalling cytokines are released from cells in the circulation (Akira et al., 1993), as well as 
skeletal muscle (Steensberg et al., 2000), studies routinely assess cytokine concentrations in 
plasma.  
 
1.8 Hormesis: Understanding the adaptive and pathological roles of oxidative stress and 
inflammation 
1.8.1. Overview 
Hormesis is a theory proposing that biological systems respond to radiation, 
chemicals and toxins with a bell-shaped curve relationship (Rattan, 2001). The theory 
suggests that there is an ‘optimal’ dose of these stimuli before the beneficial effects on 
cellular adaptation decline. 
 
1.8.2. Acute exercise-induced oxidative stress and human disease 
Radak and colleagues (Radak et al., 2005) extended the concept of hormesis to 
suggest that the beneficial effects of exercise are in part, related to exercise-induced RONS 
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production (figure 1.6). The theory is termed the ‘exercise paradox’ and relates to the 
unknown balance or threshold between RONS that have an adaptive or pathological outcome. 
This theory might suggest that in populations with high underlying levels of oxidative 
stress, that exercise of a prolonged or high intensity might produce levels of RONS that 
exceed the hormesis threshold and damage cellular biomolecules (Packer, 1997; Radak et al., 
1999). Indeed, there is some evidence suggesting that exercise-induced RONS release is 
related to exercise intensity (Wang and Huang, 2005; Goto et al., 2003) and duration 
(Bloomer et al., 2007).  
Previous studies in patient populations have indicated not only higher baseline 
differences compared to control but also an exaggerated oxidative stress response (i.e. 
percentage increase) to an exhaustive bout of exercise (Nishiyama et al., 1998; Avogaro et al., 
1986). Whilst the significance of this exaggerated response is not completely clear, these 
studies demonstrate that there may be an optimal balance between the production of RONS in 
response to exercise that initiates adaptation and the amount that elicits damage. Interestingly, 
some previous studies have also highlighted an exaggerated inflammatory response to 
exercise in patients populations, compared to age-matched controls (Ploeger et al., 2009; 
Castellano et al., 2008). Exaggerated oxidative stress and inflammatory responses to exercise 
may be explained by disease associated deteriorations in cellular structure and function, 
combined with a reduced capacity for the muscle to repair and regenerate (McArdle et al., 
2002). Furthermore, the heightened basal levels of oxidative stress and inflammation in 
patients groups might impair their ability to protect against the stress of the exercise 
compared to healthy subjects.  
Exercise is an extremely beneficial behavioural intervention to improve and optimise 
health. Evidence suggests that maintaining low basal levels of oxidative stress and 
inflammation can help extend lifespan and prevent disease. The model of hormesis suggests 
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that transient exercise-induced increases in RONS are essential in facilitating adaptations that 
help maintain lower basal levels of oxidative stress over time. However, the dose (i.e. 
intensity, frequency, duration and modality) of exercise that can achieve optimal adaptations 
remains unclear. Importantly, this may differ between populations. In diseases associated 
with inflammation, a fine line may exist between the production of RONS and inflammatory 
cytokines that can achieve optimal adaptation, and the amount that may cause damage. 
Monitoring peripheral blood oxidative stress and inflammation in response to various types of 
exercise, in populations of differing health status’ and over periods of training can give us 
insight into the adaptive and pathological actions of oxidative stress and inflammation in 
health and disease. 
 
Figure 1.6:   Model of Exercise-induced RONS and Hormesis. The theoretical model 
suggests that there is a threshold whereby certain situations (health status, exercise conditions) 
may compromise exercise adaptation stimulated by RONS, leading to impaired adaptation 
and health outcomes. 
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1.9. Aims of thesis 
The aims of this thesis were to explore and characterise acute and chronic changes in 
markers of oxidative stress and inflammation in response to various stimuli, with a primary 
focus on exercise. The main objectives were to assess the impact of exercise modality, 
intensity and health status on these markers. Finally, a consistent aim was to 
identify/investigate markers that might provide insight into the links between oxidative stress 
and inflammation. Characterising the perturbations of oxidative stress and inflammation in 
response to ‘stress’ are essential in aiding understanding of the roles of RONS and 
inflammatory cytokines in health and disease. Furthermore, this information may facilitate 
the development of practical suggestions on the use of exercise as a tool to maintain or 
improve health in a variety of populations. The overarching hypothesis of this thesis was that 
exercise would induce intensity-dependent changes in markers of oxidative stress and 
inflammation. It was also hypothesised that exercise in rheumatoid arthritis patients would 
cause a transient increase in oxidative stress that would aid reductions in baseline oxidative 
stress over a period of exercise training. 
The study presented in Chapter two aimed to characterise oxidative stress and 
inflammation in response to acute mental stress, under conditions of high or basal 
inflammation. Vaccination and exercise-induced muscle damage were used as experimental 
interventions to induce inflammation in this study. Chapter three aimed to investigate the 
effects of acute and chronic exercise on markers of oxidative stress and inflammation in 
patients with rheumatoid arthritis. Chapter four looked to characterise acute physiological 
responses to low volume high intensity interval training (LV-HIIT); a recently designed novel 
training modality for sedentary and clinical populations. Plasma markers of oxidative stress 
and inflammation were assessed in response to an acute bout of LV-HIIT and compared with 
more conventional steady state exercise bouts in healthy participants. Finally, chapter five 
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aimed to establish the response of cellular redox proteins (TRX and PRDX) to LV-HIIT and 
steady state exercise bouts in healthy participants.  
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Chapter Two 
2. Underlying inflammation has no impact on the oxidative 
stress response to acute mental stress 
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2.1. Abstract 
Introduction: Mental stress is considered to be a trigger for acute myocardial infarction (MI), 
with inflammation thought to provide a mechanism. Inflammation is reciprocally linked to 
oxidative stress, which has also been implicated in MI. The purpose of this study was to 
assess the effects of experimentally-induced inflammation on the oxidative stress response to 
mental stress in healthy participants.  
Methods: Healthy males undertook one of two inflammatory stimuli: typhoid vaccination 
(Vaccination paradigm, N=17) or eccentric exercise (Eccentric exercise paradigm, N=17). All 
participants completed a mental arithmetic stress task twice: six hours after the inflammatory 
stimulus, and during a control non-inflammation condition. Blood samples were taken before, 
immediately and thirty minutes after the stress task. Plasma was assessed for interleukin-6 
(IL-6), protein carbonyls (PC), lipid hydroperoxides (LOOH), total antioxidant capacity 
(TAC) and nitric oxide metabolites (NOx). 
Results: Vaccination paradigm: IL-6, PC and NOx were significantly higher in the 
vaccination condition, relative to the control condition (p<.05). PC, TAC, LOOH and NOx 
were unchanged in response to mental stress in both the vaccination and control conditions. 
Eccentric Exercise paradigm: IL-6 and TAC were significantly higher in the eccentric 
exercise condition (p<.05), relative to the control condition. PC, TAC and NOx were 
unchanged in response to mental stress in both the eccentric exercise and control conditions.  
Conclusions: Two different inflammatory paradigms were successful in increasing plasma 
markers of inflammation and oxidative stress prior to a mental stress task. However, 
experimentally induced transient inflammation had no impact on mental stress-induced 
changes in plasma LOOH, PC, TAC or NOx in young healthy participants. 
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2.2. Introduction 
Mental stress has been proposed as a potential trigger for myocardial infarction (MI) 
(Strike and Steptoe, 2005; Bergovec et al., 1992). The physiologic mechanisms linking 
mental stress to MI have not been fully clarified, however inflammation has been implicated 
(Wilbert-Lampen et al., 2010; Paine and Veldhuijzen van Zanten, 2012). Laboratory models 
have been used to investigate the role of inflammation in populations with elevated risk for 
cardiovascular disease and findings have shown that mental stress-induced ischemia is 
associated with future MI (Babyak et al., 2011; Krantz et al., 1999). Interestingly, mental 
stress-induced ischemia is more prevalent in those with higher baseline levels of 
inflammation (Shah et al., 2006). Inflammation is known to be intrinsically linked to 
oxidative stress, a state whereby the production of reactive oxygen species (ROS) 
overwhelms antioxidants (Wadley et al., 2012). Both oxidative stress and inflammation are 
independently associated with the development of cardiovascular disease (CVD) and MI (Cai 
and Harrison, 2000; Dhalla et al., 2000; Ross, 1999). Given the adverse effect of oxidative 
stress on MI risk, the relationship between mental stress and oxidative stress warrants further 
investigation. 
The few studies that have investigated the links between oxidative stress and acute 
mental stress have primarily been in either animals (Madrigal et al., 2001; Bagchi et al., 1999) 
or observational studies in humans (Sivonova et al., 2004; Lesgards et al., 2002). For 
example, medical students undergoing a stressful examination period demonstrated increased 
DNA and lipid oxidation, as well as a deceased antioxidant capacity when compared to a 
non-stressful period of their life (Sivonova et al., 2004). Conversely, individuals delivering 
public speeches showed increased urinary concentrations of bilirubin oxidative metabolite, an 
abundant antioxidant compound, compared to a control group who did not perform a public 
speaking task (Yamaguchia et al., 2002). Similar disparity exists with acute mental stress and 
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ROS production, with studies indicating increased (Bagchi et al., 1999) and suppressed 
(Atanackovic et al., 2002) production. Collectively these studies warrant careful 
interpretation due the different study designs, categorisations of stress, measures of oxidative 
stress and the time points assessed. To our knowledge only one previous investigation has 
assessed the acute oxidative stress response to a controlled laboratory mental stress task 
(Huang et al., 2010). In this study, total antioxidant capacity (TAC) was not perturbed in 
response to mental stress, however there are potential mechanisms which could explain an 
increase in oxidative stress in response to mental stress. For example, the well documented 
ROS burst from inflammatory neutrophils (Babior et al., 1973) could follow from a mental 
stress-induced inflammatory response (Veldhuijzen van Zanten et al., 2005; Brydon et al., 
2005). Furthermore, altered blood flow and shear stress patterns (i.e. oscillatory shear) in 
response to mental stress (Veldhuijzen van Zanten et al., 2009) could generate ROS via 
vascular oxidases (Harrison et al., 2003), thus enhancing oxidative stress. Finally, a direct 
mechanism between oxidative stress and mental stress-induced MI might be explained by the 
actions of the diverse reactive nitrogen species (RNS), nitric oxide (NO). NO can regulate 
blood vessel dilation and vascular health (Lewis et al., 1999), however its function may be 
inhibited by mental stress-induced sequestering of NO by ROS (Beckman, 1996). Despite 
these potential mechanisms, the sources of oxidative stress and the mechanisms leading to MI 
as a result of mental stress have yet to be explored in detail.  
There is evidence to suggest that ROS can trigger inflammatory pathways in humans 
(Naik and Dixit, 2011), and inflammation is known to drive ROS production (Babior et al., 
1973). Studies in clinical populations with high underlying inflammation have reported an 
exaggerated inflammatory response to acute mental stress (Kop et al., 2008; Veldhuijzen van 
Zanten et al., 2008). It should be noted that, due to the underlying factors associated with 
these clinical populations (e.g., other cardiovascular risk factors), it is impossible to explore 
 
 
45 
 
the direct effect of inflammation. As a result, laboratory based models have been used to 
induce an inflammatory response in healthy subjects (Clapp et al., 2004; Hingorani et al., 
2000) and recently to specifically investigate the role of inflammation on mental stress-
induced responses (Paine et al., 2013a). These studies have demonstrated that an acute rise in 
inflammation can influence the vascular responses to mental stress. However, the impact of 
baseline inflammation on the oxidative stress response to mental stress has yet to be 
examined. 
Eccentric exercise-induced muscle damage and vaccination (Salmonella typhi 
(typhoid) capsular polysaccharide vaccine) have previously been used as models to induce 
systemic inflammation. In these studies, a peak inflammatory cytokine response was 
observed 6 hours following both inflammatory stimuli (MacIntyre et al., 2001; Paulsen et al., 
2005; Paine et al., 2013b; Antoniades et al., 2011). The use of a low dose typhoid vaccination 
to induce a mild systemic inflammatory response is typically safe and approved by the US 
food and drug agency (Hingorani et al., 2000; Strike et al., 2004; C.E. Wright, , P.C. Strike, L. 
Brydon, 2005). The administration of a mild pathogen can stimulate the adaptive immune 
system to respond by mobilising white blood cells and increasing the production of 
inflammatory cytokines. Importantly, it has been demonstrated that a needle injection alone 
does not cause a significant inflammatory response (Paine et al., 2013b). Similarly, eccentric 
exercise is commonly used as a safe experimental manipulation to study acute increases in 
inflammation (Paine et al., 2013a). Elongation of the activated muscle under tension can 
create a localised inflammatory response within the muscle that can infiltrate the systemic 
circulation (Nosaka et al., 2002; Proske and Morgan, 2001). In both of these models, the most 
typically studied inflammatory marker is Interleukin (IL-6), an acute phase protein with an 
active role in the inflammatory response (Papanicolaou et al., 1998). Importantly, IL-6 is a 
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commonly used inflammatory marker in response to mental stress in the literature (Steptoe et 
al., 2007). 
To our knowledge no previous studies have explored changes in multiple markers of 
oxidative stress to acute mental stress following experimental manipulations of baseline 
inflammation. The aim of the current investigation was to use two inflammatory paradigms 
(vaccination and eccentric exercise) to assess how plasma markers of oxidative stress were 
perturbed in response mental stress. It was hypothesised that mental stress would elicit 
increases in oxidative stress, and that higher baseline levels of inflammation would 
exaggerate this response.  
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2.3. Methods 
2.3.1. Participants 
Vaccination paradigm 
Seventeen healthy males were recruited from the University of Birmingham. All 
participants gave their informed written consent and the vaccination paradigm of the study 
was approved by NHS Black Country NRES ethics committee. None of the participants had 
recently suffered from acute illness or infection. No participants reported a history of immune 
disorders, cardiovascular or other chronic inflammatory diseases and all participants were 
non-smokers. Participants were asked to refrain from vigorous exercise, alcohol and foods 
high in dietary nitrate 24 hours prior to testing. Participants were also asked to abstain from 
food and caffeine two hours beforehand. No participants had received a Salmonella typhi 
capsular polysaccharide vaccine in the preceding year.  
 
Eccentric Exercise paradigm 
Seventeen healthy males were recruited from the University of Birmingham. The 
same exclusion and adherence criteria were used as indicated in the vaccination paradigm. In 
addition, all participants were unaccustomed to regular eccentric exercise training. As with 
the vaccination paradigm, participants gave their informed written consent and the eccentric 
exercise paradigm was approved by the appropriate ethics committee at the University of 
Birmingham. 
 
2.3.2. Vaccination Protocol  
Participants received an intra-muscular injection of S. typhi capsular polysaccharide 
vaccine (0.025mg in 0.5ml, Typhim Vi, Sanofi Pasteur, UK) into the deltoid muscle of the 
non-dominant arm. A trained nurse administered and then monitored the participant for half 
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an hour following injection. Participants then completed questionnaires for demographic and 
medical purposes, as well as questionnaires addressing symptoms associated with the 
injection. 
 
2.3.3. Eccentric Exercise Protocol  
The eccentric exercise protocol was adapted from a previous study (Jackman et al., 
2010). Using a Cybex leg extension machine (Cybex International Medway, MA), the 1 
repetition maximum (1RM) of participant’s non-dominant leg was determined. From a flexed 
position, participants were required to concentrically lift their leg into an extended position 
and hold for 2 seconds. 1RM was determined within 5 attempts to avoid fatigue. The 1RM 
was established when participants could no longer lift or hold the weight for longer than 2 
seconds. The eccentric exercise task was then explained to participants before completing a 
practice set at 50% 1RM to ensure an understanding of the task action. The task required 
participants to lower the weight (120% 1RM) with their dominant leg from an extended 
position (15 degrees flexion) to a flexed position (110 degrees flexion) over a 4 second period. 
Two experimenters lifted the weight into the extended position between repetitions. The 
protocol required participants to complete 12 sets of 5 repetitions with 5 seconds rest between 
each repetition and 1 minute rest in-between each set. Incomplete repetitions (i.e. where the 
weight was lowered in less than 4 seconds) were repeated. Participants then completed 
questionnaires for demographic and medical background purposes. 
 
2.3.4. Control Protocol 
In the eccentric exercise paradigm of the study, participants rested quietly for 25 
minutes and then completed questionnaires administered for demographic and medical 
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background information. No visit was required for subjects in the vaccination paradigm of the 
study. 
 
2.3.5. Mental Stress Task 
A 16-minute version of the paced auditory serial addition task (PASAT) was used to 
induce acute mental stress in all participants (Veldhuijzen van Zanten et al., 2005). A series 
of single digit numbers were dictated to participants via a CD player. The objective was to 
add each number to the previous number, vocalising the response to an accompanying 
demonstrator who was sat 1 metre away (Gronwall, 1977; Ring et al., 2002). Participants 
completed two 8 minute tasks, with a 1 minute interval between each task. The first task 
consisted of four consecutive 2 minute blocks, delivered at inter-stimulus rates of 2.8, 2.4, 2.0 
and 1.6 seconds. The second task used inter-stimulus rates of 2.4, 2.0, 1.6 and 1.2 seconds, 
with the decrease in inter-stimulus rates increasing task difficulty. Additionally, several other 
experimental manipulations were implemented to enhance the mental stress response 
(Veldhuijzen van Zanten et al., 2004). The demonstrator checked participant responses 
against the correct answers, and a loud aversive noise was sounded within each block of 10 
numbers upon the first incorrect or late response, or at the end of each block if no incorrect 
response was given. Participants were videotaped and instructed to focus their attention on a 
screen showing their face throughout the task. This manipulation was under the false 
instruction that they were being analysed by independent body language experts. Finally, a 
leader board was placed within subject eye line to promote competitiveness, and a promise of 
£10 for the highest study score in their first session and most improved score in session two. 
These experimental manipulations have been previously shown to increase provocativeness 
of the task by increasing demands such as time pressure, social evaluation, punishment and 
reward (Veldhuijzen van Zanten et al., 2004; MacIntyre et al., 2001; Woollard et al., 2002).  
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2.3.6. Procedure 
Participants were subjected to one of the inflammatory paradigms (vaccination or 
eccentric exercise). All participants conducted the stress reactivity session twice, which were 
scheduled at least seven days apart: once in an inflammation condition and once in a control 
condition. Both inflammation conditions involved a morning visit (starting: 08.00-10.00), 
during which the protocols described above was carried out, and an afternoon (starting 14.00-
16.00) visit, during which the stress reactivity session was conducted. (figure 2.1). The six 
hour time window between the visits was based on previous research that indicates a peak 
inflammatory cytokine response to typhoid vaccination (Paine et al., 2013b) and eccentric 
exercise at this time point (MacIntyre et al., 2001). In the morning of the control condition, 
participants were either asked to attend the laboratory to complete questionnaires (eccentric 
exercise paradigm) or no visit was needed (vaccination paradigm). At the start of the first 
reactivity session, participants were asked to complete a diet questionnaire. A copy was then 
given to each participant and they were asked to repeat their diet before the second reactivity 
session. 
 
2.3.7. Stress Reactivity Session 
Following the assessments of height and weight (Seca Alpha, Hamburg, Germany), 
participants lay in a supine position for the remainder of the session. A small cuff was placed 
around the middle finger of the dominant hand for continuous recordings of heart rate (HR), 
systolic (SBP) and diastolic blood pressure (DBP) throughout the session (Finapres Medical 
Systems; Amsterdam, The Netherlands). Data was recorded via a Power 1401 (CED) 
connected to a computer with Spike 2 analysis software (version 6). A catheter (Becton, 
Dickson & Company, Oxford, UK) was inserted into the antecubital vein of the dominant 
arm. The catheter was kept patent throughout the session with regular saline flushes. 
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Participants rested for 20 minutes whilst watching a BBC nature documentary, with a blood 
sample taken (baseline). Following a practice, participants completed the mental stress task as 
detailed above. A blood sample was taken during the last minute of the second PASAT block 
(stress). Participants then completed a 30 minute recovery period, which involved 
participants resting in the supine position whilst watching a BBC nature documentary. A 
blood sample was taken at the end of this period (post+30). Blood (12 ml per time point) was 
collected into vacutainers containing potassium ethylene diaminetetraacetic acid, stored on 
ice until centrifugation (1500g for 10 minutes at 4°C) and plasma aliquoted and stored at -
80°C for future analyses. 
 
 
 
Figure 2.1:  Stress Reactivity Session: A schematic representation of the study protocol. 
 
2.3.8. Blood Analyses 
Blood samples were assessed for blood cell composition, specifically total white 
blood cells, granulocytes, monocytes and lymphocytes. Haemoglobin (g/dL) and haematocrit 
(%) were assessed to calculate plasma volume changes as a result of mental stress (Coulter 
Analyser, Beckman-Coulter, High Wycombe, UK) (Kargotich et al., 1997). All reagents 
purchased from Sigma unless stated (Sigma Aldrich, Dorset, UK). 
Baseline rest (20 min) 8 min PASAT Recovery period (30 min)
Stress Task = 16 min 
(1 minute rest)
Key
= Blood sample
BASE STRESS POST+30
8 min PASAT
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Total Antioxidant Capacity 
TAC was assessed using the Ferric Reducing Ability of Plasma (FRAP) assay (Benzie 
and Strain, 1996).  Plasma samples (10 µl per well) and standards (ascorbic acid, 0-1000 µM; 
10 µl) were added in triplicate to a flat bottomed 96 well plate.  FRAP reagent (300 mM 
sodium acetate (pH=3.6), 160 mM 2, 4, 6- tripyridyltriazin  and 20mM ferric chloride; 300 µl) 
was added to each well and left to incubate for 8 minutes at room temperature, then 
absorbances read at 650 nm. TAC values were obtained using absorbance values of known 
ascorbic acid concentrations, expressed as µM of antioxidant power relative to ascorbic acid 
(McAnulty et al., 2005) and adjusted for changes in plasma volume. 
  
Protein Carbonylation (PC)   
PC was assessed by ELISA (Buss et al., 1997; Carty et al., 2000) in order to quantify 
the degree of protein oxidation in plasma samples.  Samples were diluted in coating buffer 
(50mM sodium carbonate, pH=9.2) to a concentration of 0.05mg/ml.  Samples and standards 
(50µl) were added in triplicate to a 96 well NUNC maxisorb microtitre plate for 1 hour at 
room temperature. Bound protein was then incubated in the dark for 1 hour at room 
temperature with 2, 4-dinitrophenylhydrazine (DNPH) (1mM, in 2M HCl).  All wells were 
then blocked (200µl) with TBS Tween (0.1%) overnight at 4°C.  Wells were incubated with 
monoclonal mouse anti-DNP antibody (50µl, 1:1000) for 2 hours at room temperature, 
followed by peroxidase conjugated rat anti-mouse IgE conjugated HRP (50µl, 1:5000, AbD 
Serotec, Oxford, UK) for 1 hour at room temperature.  All steps were followed by three 
washes to the 96 well plate using TBS Tween (0.05%).  Substrate (0.5M Citrate phosphate 
buffer (10mls, pH=5), hydrogen peroxide (8µl) and Ortho-Phenylenediamine tablet (2mg); 
50µl) was added to each well and the reaction stopped after 20-25 minutes with 2M sulphuric 
acid (50µl).  Each well was measured for absorbance at 490nm (Multiscan MS, Labsystems) 
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and quantified using absorbance values of PC standards made in our lab (1.28 - 5.20 
nmols/mg of protein).  
 
Preparation of protein carbonyl standards 
Ratios of oxidised (2,2'-Azobis(2-amidinopropane dihydrochloride, 500 mM) to 
reduced (Sodium Borohydride, 540 mM) bovine serum albumin (BSA, 10 mg/ml in PBS) 
were prepared and carbonyl content determined as previously described (Buss et al, 1997). 
Briefly, standards (0-100% oxidation, 2 mg/ml) were incubated in DNPH (10 mM, 500 µl) or 
HCL (Control: 2M, 500 µl) for 1 hour at room temperature with gentle agitation. Protein was 
precipitated using trichloroacetic acid (20%), vortexed and centrifuged (13,000 rpm, 3 
minutes). The supernatant was removed and protein pellet washed three times in ethyl acetate: 
ethanol solution (1:1), with intermittent centrifugation (13,000 rpm, 1 minute). Standards 
were then incubated in guanidine hydrochloric acid (37 °C, 60 minutes) and absorbances read 
at 360 nm. Carbonyl content was determined as nmols/mg protein using an extinction co-
efficient (ε340 = 24600 M-1cm-1), and adjusted relative to the absorbance of the control 
sample.  
 
Protein Concentration 
Sample protein concentrations were determined using the bicinchoninic assay method 
(Smith et al., 1985). Briefly, samples (10 µl) and standards (BSA; 0-1 mg/ml, 10 µl) were 
added to a 96 well microtitre plate in triplicate. Bicinchoninic acid detection reagent (BCA), 
supplemented with copper II sulphate (20 µl / ml BCA) was added to each well (200 µl) and 
incubated in the dark for 30 minutes at room temperature. Absorbances were read at 540nm, 
and protein concentrations were determined using absorbance values of known BSA protein 
concentrations (0 – 1 mg/ml). 
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Lipid Hydroperoxides 
LOOH concentrations were assessed using a spectrophotometric assay (El-Saadani et 
al., 1989). Plasma samples and a blank standard (10 μl) were added to a 96 well microtitre 
plate in triplicate. Reagent mix (100 µl, 0.2 M Potassium phosphate (pH=6.2), 0.12 M 
potassium iodide, 0.15 mM sodium azide, Triton X (2 g/l), alkylbenzyldimethlammonium 
(0.1 g/l), 10 µM ammonium molbdate and HPLC grade water (to make total volume 100 ml)) 
was added for 30 minutes at room temperature, away from light on a plate shaker. The plate 
was read at 340nm (Multiscan MS, Labsystems), concentration of lipid peroxides (μmol/l) 
determined using the Beer-Lambert Law (extinction co-efficient ε340 = 24600 M-1cm-1) and 
adjusted for changes in plasma volume. 
 
Nitrite and Nitrate (NOx metabolites) 
 The Griess assay was used to quantify total nitric oxide metabolites (NOx) in plasma 
samples (Miranda et al., 2001; Moshage et al., 1995). Samples (100 µl) were diluted with 
HPLC grade water (375 µl) and zinc sulphate (25 µl, 300 mg/ml) to give a concentration of 
approximately 15 mg/ml.  Samples were vortexed and then centrifuged at 10,000 g for 20 
minutes (10 °C). Supernatants and standards (100 µl) were added to a 96 well microtitre plate 
in triplicate, and 100 µl vanadium (III) chloride (8 mg/ml) then added. Thorough mixing was 
ensured to fully reduce plasma nitrate to nitrite. Sulphanilamide (50 µl, 2 %) and N-(1-
naphthyl) ethylendiamine dihydrochloride (50 µl, 0.1 %) were then rapidly added to each 
well. Plates were incubated for 30 minutes at 37°C, absorbance read at 540nm and compared 
with values of known nitrite concentrations (0-100μM). Values were adjusted for changes in 
plasma volume. 
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Interleukin-6 
Plasma concentrations of IL-6 were determined using a commercially available High-
Sensitivity ELISA kit according to manufacturer instructions (R&D Systems). Briefly, 
samples (200 µl, diluted 1:1 with assay diluent) were incubated with a monoclonal antibody 
(200 µl) derived against IL-6, and then substrate (50 µl) and amplifier (50 µl) solutions added 
to develop the colour change. Plates were washed intermittently to reduce non-specific 
binding. The reaction was stopped using 2 M sulphuric acid (50 µl) and absorbance’s read at 
650nm. Values were then obtained from a linear standard curve of known IL-6 concentrations 
(0.156-10 pg/ml) and adjusted for changes in plasma volume. 
 
2.3.9. Data reduction and analysis 
Heart rate, SBP and DBP were recorded continuously throughout the stress reactivity 
session. Data was analysed during minutes 14, 16, 18, and 20 of the baseline rest period, at 2-
minute intervals during the stress task and at minutes 24, 26, 28, and 30 of the recovery 
period. Subsequently, the values were averaged to derive an overall baseline, stress and 
post+30 value for HR, SBP and DBP. Statistical analyses were performed using SPSS 
(PASW Statistics, release 18.0, SPSS Inc., Chicago, IL, USA). Differences in baseline IL-6 
values were assessed by independent samples t-tests. The effects of mental stress on oxidative 
stress and cardiovascular activity were assessed by 2 condition (vaccination or eccentric 
exercise, control) by 3 time (baseline, stress and post+30) repeated measures ANOVA, with 
Greenhouse-Geisser correction (Vasey and Thasey, 1987). Post hoc analysis of the 
interaction effects was performed by a test of simple effects by pairwise comparisons, with 
Bonferroni correction. Pearson correlations were conducted to examine associations between 
baseline inflammation and oxidative stress with changes in LOOH, PC, TAC or NOx from 
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baseline to stress. These analyses were performed separately for control and inflammatory 
conditions. Statistical significance was accepted at the p <.05 level.  
2.4. Results 
2.4.1. Vaccination paradigm 
 
Vaccination induced inflammation 
Table 2.1 describes the characteristics of the participants in the vaccination paradigm 
of the study. Figure 2.2 outlines IL-6 concentrations at baseline in the control and vaccination 
conditions. IL-6 concentrations in the vaccination condition were higher than in the control 
condition (p <.001), confirming that vaccination increased inflammation prior to the start of 
the stress task. 
 
Table 2.1:  Characteristics of participants in the vaccination paradigm (Mean ± standard 
deviation) 
 
 
 
Participant Characteristics (N=17)
Age (yrs) 20 (1)
Weight (kg) 81.3 (9.4)
Height (m) 1.8 (0.1)
BMI (kg/m2) 24.5 (2.2)
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Figure 2.2:  IL-6 concentrations at baseline in control and vaccination conditions. # indicates 
a significant difference between control and vaccination conditions (p <.05) 
 
White blood cell subset responses 
The effects of mental stress on white blood cell subsets in the vaccination paradigm 
are shown in Table 2.2. Total white blood cell and granulocyte numbers were higher in the 
vaccination condition relative to the control condition (condition effects; p’s <.001). Total 
white blood cell, granulocyte and lymphocyte numbers increased, and monocyte number 
decreased in response to mental stress in both conditions (time effects: p <.026). Pairwise 
comparisons revealed that lymphocyte number increased during stress, relative to baseline in 
both conditions (time effect: p =.001) and decreased, relative to stress post+30 (time effect: p 
=.027). There was a significant condition * time interaction effect for total white blood cell 
number. Post hoc analyses revealed that total white blood cell number was elevated during 
stress in both conditions, but remained elevated post+30, relative to baseline in the control 
condition only.  
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Table 2.2: White blood cell subset concentrations (mean ± standard deviation) at baseline, 
stress and post+30 in the control and vaccination conditions 
 
* indicates significant differences relative to baseline (p<.05). # indicates significant 
differences relative to stress (p<.05).   
 
Cardiovascular responses 
Figure 2.3 (left panel) outlines the cardiovascular responses to the mental stress task 
in control and vaccination conditions. HR increased over the course of the mental stress task 
and returned to baseline values in both conditions (time effects; p <.001). SBP and DBP 
increased over the course of the stress task and remained elevated above baseline values 
post+30 (time effects; p’s <.05). No differences were observed in HR, SBP and DBP between 
conditions. 
 
 
 
 
Control Condition Vaccination Condition
Time effect
Condition 
effect
Time * 
condition 
effectBaseline Stress Post+30 Baseline Stress Post+30
White Blood 
Cells (×109/L)
5.98 ±
0.28
6.43 ±
0.27*
6.76 ±
0.29*
9.32 ±
0.35
9.69 ±
0.29*
9.53 ±
0.27
p<.001 p<.001 p=.024
Granulocytes
(×109/L)
3.96 ±
0.29
4.23 ±
0.27
4.82 ±
0.30
6.94 ±
0.30
6.79 ±
0.46
7.87 ±
0.58
p=.026 p<.001 p=.597
Monocytes
(×109/L)
0.39 ±
0.17
0.36 ±
0.12
0.27 ±
0.10
0.43 ±
0.19
0.43 ±
0.18
0.35 ±
0.19
p=.026 p=.098 p=.772
Lymphocytes
(×109/L)
1.76 ±
0.31
1.94 ±
0.31*
1.79 ±
0.26#
1.88 ±
0.28
2.01 ±
0.27*
1.91 ±
0.35#
p=.002 p=0.096 p=.605
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Figure 2.3:  Cardiovascular responses to mental stress. The changes in heart rate (A), systolic 
blood pressure (B) and diastolic blood pressure (C) at baseline, during and 30 minutes 
following the mental stress task in both the control (grey bars) and inflammation (black bars)  
condition in the vaccination paradigm (left panel) and the eccentric exercise paradigm (right 
panel). Data are means ± standard error. * indicates significant differences relative to baseline 
in the control condition (p <.05). ** indicates significant differences relative to baseline in the 
inflammation condition (p <.05). # indicates significant differences relative to stress in the 
control condition (p <.05). ## indicates significant differences relative to stress in the 
inflammation condition (p <.05) 
 
Oxidative stress responses 
Figure 2.4 (left panel) outlines the changes in markers of oxidative stress and nitric 
oxide metabolites in response to the mental stress task in control and vaccination conditions. 
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PC and NOx values were higher in the vaccination condition than the control condition 
(condition effects; p’s <.05). TAC, PC, LOOH and NOx were unaltered in response to mental 
stress in both conditions (time effects: p’s > .126).  
 
 
 
 
Figure 2.4:  Oxidative stress responses to mental stress. The changes in TAC (A), PC (B), 
LOOH (C) & NOx (D) at baseline, stress and 30 minutes following the mental stress task in 
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both the control (grey bars) and inflammation (black bars) condition in the vaccination 
paradigm (left panel) and the eccentric exercise paradigm (right panel). Data are means ± 
standard error. ** indicates significant changes relative to baseline (p <.05). # indicates a 
significant difference between control and inflammatory conditions (p <.05). 
 
Associations between baseline oxidative stress and inflammation and oxidative stress 
responses to mental stress 
No associations were observed when assessing the influence of baseline markers of 
oxidative stress and inflammation on the LOOH, PC, TAC or NOx response to mental stress 
in control or vaccination conditions. 
 
2.4.2. Eccentric exercise paradigm 
 
Eccentric exercise induced inflammation  
Table 2.3 describes the characteristics of the participants in the eccentric exercise 
paradigm of the study. Figure 2.5 outlines IL-6 concentrations in the control and eccentric 
exercise conditions. IL-6 concentrations in the eccentric exercise condition were higher than 
in the control condition (p =.01), confirming that eccentric exercise had increased 
inflammation prior to the start of the stress task.  
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Table 2.3: Characteristics of participants in the eccentric exercise paradigm (Mean ± standard 
deviation) 
 
 
 
Figure 2.5:  IL-6 concentrations at baseline in control and eccentric exercise conditions. # 
indicates a significant difference between control and vaccination conditions (p <.05) 
 
White blood cell subset responses 
The effect of mental stress on white blood cell subsets in the eccentric exercise 
paradigm is shown in Table 2.4. Total white blood cell number increased during stress in 
both conditions (p =.007), with no differences observed between conditions. No differences 
in lymphocyte, monocyte or granulocyte numbers were observed in response to mental stress 
Participant Characteristics (N=17)
Age (yrs.) 21 (1)
Weight (kg) 76.6 (8.8)
Height (m) 1.8 (0.1)
BMI (kg.m2) 23.6 (2.4)
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or between conditions. There were no condition * time interaction effects for the white blood 
cell subsets. 
 
Table 2.4:  White blood cell subset concentrations (mean ± standard deviation) at baseline, 
stress and post+30 in the control and eccentric exercise conditions 
 
* indicates significant differences in baseline values relative to the control conditions (p<.05).  
# indicates significant differences in values relative to stress (p<.05). 
 
Cardiovascular responses 
Figure 2.3 (right panel) outlines the cardiovascular responses to the mental stress task 
in control and eccentric exercise conditions. Heart rate increased immediately following the 
mental stress task and returned to baseline values in both conditions (time effect; p <.001). 
SBP and DBP increased immediately following the mental stress task and remained elevated 
above baseline values post+30 (time effects; p’s <.05). No differences were observed in HR, 
SBP and DBP between conditions. 
 
Control Condition Eccentric Exercise Condition
Time effect
Condition 
effect
Time * 
Condition 
effectBaseline Stress Post+30 Baseline Stress Post+30
White Blood 
Cells (×109/L)
6.03 ±
0.17
6.44 ±
0.26*
6.32 ±
0.32
6.34 ±
0.37
6.76 ±
0.42*
6.61 ±
0.41
p=.007 p=.293 p=.937
Granulocytes
(×109/L)
3.77 ±
0.87
3.81 ±
1.17
3.72 ±
1.12
4.14 ±
1.27
4.31 ±
1.47
4.23 ±
1.37
p=.315 p=.102 p=.549
Monocytes
(×109/L)
0.30 ±
0.33
0.27 ±
0.33
0.43 ±
0.39
0.38 ±
0.21
0.43 ±
0.29
0.50 ±
0.38
p=.115 p=.297 p=.678
Lymphocytes
(×109/L)
2.03 ±
0.35
2.18 ±
0.39
2.30 ±
0.81
1.99 ±
0.65
2.04 ±
0.41
1.88 ±
0.32
p=.607 p=.106 p=.154
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Oxidative stress responses 
Figure 2.4 (right panel) outlines the changes in markers of oxidative stress and nitric 
oxide metabolites in response to the mental stress task in control and eccentric exercise 
conditions. TAC values were higher in the inflammation condition compared to the control 
condition (condition effect; p =.011). TAC, PC and NOx were unaltered in response to 
mental stress in both conditions. LOOH decreased in response to mental stress in the 
eccentric exercise condition only (time effect; p <.05).  
 
Associations between baseline oxidative stress and inflammation and oxidative stress 
responses to mental stress 
An association was found between baseline LOOH values and changes in LOOH between 
baseline and stress in the eccentric exercise condition only (r=-0.635, p<.003). No other 
associations were observed when assessing the influence of baseline makers of oxidative 
stress and inflammation on the PC, TAC or NOx response to mental stress in control or 
eccentric exercise conditions. 
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Discussion 
 The current study demonstrates that vaccination and eccentric exercise were 
successful models of inducing inflammation, as demonstrated by significantly higher IL-6 
concentrations in the inflammation conditions compared to the control conditions (figures 2.2 
& 2.5). Nevertheless, acute inflammation did not influence the oxidative stress response to 
mental stress in either paradigm of this study. 
The oxidative stress response to mental stress has previously been unclear, either 
under conditions of high or basal inflammation. Previous studies have indicated an increase 
(Sivonova et al., 2004; Bagchi et al., 1999), decrease (Atanackovic et al., 2002; Yamaguchia 
et al., 2002) and no change (Huang et al., 2010) in indices of oxidative stress (i.e. plasma 
markers and ROS levels) in response to acute mental stress and during periods of lifestyle 
stress. Oxidation of macromolecules within the body is part of normal homeostatic processes 
that regulate cellular signalling, growth and adaptations within tissues. Many lifestyle factors, 
including health history, nutritional status (Møller et al., 1996) and even internal circadian 
rhythm (Kanabrocki et al., 2002) can influence the degree of oxidative modification to these 
macromolecules. As a result, previous observational studies monitoring the impact of mental 
stress on markers of oxidative stress/ROS at one ‘snap shot’ warrant careful interpretation. In 
addition, stressful situations (i.e. exam periods (Sivonova et al., 2004) and public speaking 
(Yamaguchia et al., 2002)) and study model (human (Atanackovic et al., 2002) and animal 
(Bagchi et al., 1999) models) have varied significantly between studies, making it hard to 
draw valid and robust conclusions. To our knowledge, this was the first study utilising well 
standardised laboratory models of both acute inflammation and mental stress to test the sole 
influence of baseline inflammation on the oxidative stress responses to mental stress in 
humans. Our findings show that mental stress did not increase PC, LOOH, TAC and NOx 
under conditions of basal or experimentally manipulated elevated inflammation (figure 2.4).  
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Previous studies have suggested a role for baseline inflammation on physiological 
responses to mental stress (Veldhuijzen van Zanten et al., 2005; Shah et al., 2006; Roupe van 
der Voort et al., 2000). In the current study, we used two established experimental paradigms 
to induce inflammation in healthy participants to specifically assess the influence of 
inflammation on the oxidative stress responses to mental stress. The elevations in baseline IL-
6 concentrations in both of the inflammatory conditions, relative to control were comparable 
to values observed in patients with coronary artery disease (Kop et al., 2008) and otherwise 
apparently healthy men who then suffered a MI (Ridker et al., 2000). Thus, the experimental 
manipulations induced increase in IL-6 values which were similar to those at risk for MI. 
Furthermore, the mental stress task used in the present study elicited a physiological response 
similar to previous studies (Veldhuijzen van Zanten et al., 2004; Paine et al., 2013a; 
Veldhuijzen van Zanten et al., 2005).  Heart rate and blood pressure (figure 2.3) and total 
number of white blood cells (tables 2.2 and 2.4) increased in all conditions during the mental 
stress task. As a result we cannot attribute the lack of change in markers of oxidative stress to 
the models of inflammation or mental stress utilised in the current study.  
The potential sources of ROS in response to mental stress have not been previously 
clarified. Respiratory bursts from phagocytes (Babior et al., 1973) and increased oscillatory 
shear stress (Harrison et al., 2003) have been identified as two possible sources. Interestingly 
inflammation is known to increase the amount of circulating phagocytic cells and alter blood 
flow patterns (Nagel et al., 1994), therefore providing a clear rationale for increased oxidative 
stress in response to mental stress. The current data indicate that markers of oxidative stress 
and nitric oxide metabolism were elevated at baseline in the inflammatory conditions only 
(figure 2.4), indicating that inflammation had induced oxidative stress and NO production, 
however the same markers remained stable in response to mental stress. Interestingly, despite 
white blood cell numbers being higher at baseline in the inflammatory conditions relative to 
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control, this did not exacerbate any white blood cell responses to mental stress (table 2.2). 
Given the role of respiratory bursts on RONS production, the similarity in white blood cell 
responses in control and inflammatory conditions may explain, in part, the similar responses 
of markers of oxidative stress. 
It must be noted that a decrease in LOOH was observed in the inflammation condition 
in the eccentric exercise paradigm only (time effect: p<.05) (figure 2.4C, right panel). Further 
investigation revealed that the decrease in LOOH from baseline to post-stress was associated 
with higher baseline LOOH values (r=-0.635, p<.003). Thus, this could suggest that elevated 
levels of oxidised lipids may have been removed in response to mental stress, rather than a 
reduction in lipid oxidation per se. However, this is speculation and warrants further 
investigation. 
Given the complexity of redox events in vivo, it must be considered that specific, 
rather than global oxidative events may be occurring in response to mental stress. Oxidative 
adducts, i.e. protein and lipid modifications or altered antioxidant status are indirect markers 
of RONS-mediated actions. These markers are a good representation of non-cellular, global 
oxidative change. Further investigation is needed to monitor intracellular markers of 
oxidative stress, and cellular redox status in response to mental stress. Indeed, specific, rather 
than global oxidative changes have been observed in response to physiological stressors, such 
as exercise (Aldred and Rohalu, 2011). In addition, extensive time point analysis is required 
to account for potential ‘delayed’ responses to mental stress. Some previous studies have 
reported an increase in IL-6 within thirty minutes of stress (Burns et al., 2008; Edwards et al., 
2006). However, other studies have reported increases in markers of inflammation up to 120 
minutes following acute mental stress, with no differences observed at 30 minutes, relative to 
baseline (Brydon et al., 2004; Steptoe et al., 2001). Furthermore, physiological stimuli such 
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vaccination (Clapp et al., 2004) and exercise (Michailidis et al., 2007) have been shown to 
elicit delayed increases in markers of oxidative stress.  
It must be noted that only selective markers of oxidative stress were measured in the 
current study. Given the complexity of oxidative events in vivo, other plasma and indeed 
intracellular oxidative changes in response to mental stress cannot be dismissed. In addition, 
the measurement of leukocyte sub-set numbers and IL-6 as sole indicators of inflammation 
might be considered a limitation. However, IL-6 is an integral signalling cytokine molecule 
in the acute phase response, regulating the upregulation of numerous other inflammatory 
proteins (i.e. C-reactive protein, tumour-necrosis factor alpha and IL-1 and IL-10) and 
therefore a good representation of an inflammatory response (Febbraio et al., 2010). In 
addition, IL-6 is a known, robust responder to both vaccination (Paine et al., 2013b) and 
eccentric exercise (MacIntyre et al., 2001), peaking similarly at 6 hours. 
The current data provide evidence that experimentally manipulated baseline 
inflammation does not increase plasma oxidative stress responses to acute mental stress 
within thirty minutes in young and healthy males.  
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Chapter Three 
3. Three months of moderate intensity exercise reduced 3-
nitrotyrosine levels in rheumatoid arthritis patients 
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3.1. Abstract 
Purpose 
Rheumatoid arthritis (RA) patients display high levels of oxidative stress. Transient exercise-
induced increases in oxidative stress are thought to be adaptive in healthy populations. This 
study investigated the effect of exercise on markers of oxidative stress in RA, following acute 
exercise and a period of exercise training.  
Methods  
Acute exercise study:  RA patients (N=12, age: 56 ± 11) undertook a bout of exercise (30-40 
min, 70% VO2MAX) and blood samples were taken before and after exercise to assess markers 
of oxidative stress. Training study:  RA patients (N=19, age: 56 ± 10) were randomised into 
either a control or exercise group, who undertook 3 exercise sessions per week (30-40 min, 
70% VO2MAX) for 3 months. Plasma markers of oxidative stress (protein carbonyls (PC), 
lipid hydroperoxides (LOOH), 3-nitrotyrosine (3-NT), total antioxidant capacity (TAC) and 
catalase (CAT) activity), inflammation (interleukin-8 (IL-8) and C-reactive protein (CRP)) 
and nitric oxide metabolites (NOx) were assessed before and after training.  
Results Acute exercise study: PC (+18%) and NOx (+27%) were significantly increased 
following exercise. Training study: 3-NT decreased (2.18 ± 1.78µM to 1.10 ± 0.93µM) in the 
exercise group only, alongside increases in aerobic fitness (24.45 ± 4.98 to 27.10 ± 4.51 
ml/kg/min-1) and reductions in disease activity score (DAS: 3.47 ± 1.17 to 2.88 ± 0.76). PC, 
LOOH, TAC, IL-8, CRP and NOx concentrations, and CAT activity were unchanged in both 
groups.  
Conclusions Aerobic exercise training did not increase markers of oxidative stress in RA 
patients. 3-nitrotyrosine and disease activity were decreased following exercise training. 
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3.2. Introduction 
Rheumatoid Arthritis (RA) is a chronic systemic inflammatory disease, which is 
characterised by stiffness, swelling and progressive destruction of joints (Lee and Weinblatt, 
2001). In addition, patients with RA have an increased risk for developing cardiovascular 
disease (CVD) (John et al., 2009; Kitas and Gabriel, 2011). The high levels of inflammation 
in RA (indicated by interleukins (IL) and C-reactive protein (CRP)) may induce oxidative 
stress, a state characterised by an imbalance between the production of reactive oxygen and 
nitrogen species (RONS) and antioxidants. In addition, there is evidence implicating 
oxidative stress with both joint destruction (Mapp et al., 1995; Winrow et al., 1993; Wink et 
al., 1996) and elevated CVD risk (Griffiths et al., 2006) in RA. 
It has been suggested that oxidative stress and inflammation can reciprocally regulate one 
another (Wadley et al., 2012), with some evidence for this in RA (Vasanthi et al., 2009; 
Miyata et al., 1998). Mediators such as IL-8 can initiate respiratory bursts of RONS from 
inflammatory cells (Babior et al., 1973) and RONS can signal to upregulate IL-8 protein 
expression (Fu et al., 2002). This reciprocal relationship may exacerbate joint destruction and 
CVD risk further in RA. 
Elevated levels of nitric oxide (NO) (Farrell et al., 1992) and superoxide (O2-) (Biemond 
et al., 1986) in RA may form peroxynitrite (ONOO-). ONOO- is a RONS capable of nitrating 
amino acids to form 3-nitrotyrosine (3-NT) (Beckman et al., 1990), a stable marker of 
oxidative stress that is associated with CVD (Wattanapitayakul et al., 2000). Previous studies 
have shown that 3NT formation on isolated low density lipoproteins can facilitate the 
formation and uptake of foam cells into the blood vessel wall of RA patients (Griffiths et al., 
2006). 3-NT may therefore represent a specific marker of interest when linking oxidative 
stress with CVD risk in RA.  
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Regular exercise is associated with a reduction in multiple cardiovascular risk factors 
(Shephard and Balady, 1999) as well as improved vascular function (Clarkson et al., 1999) 
and improved joint function (Häkkinen et al., 2004). Exercise training in RA has shown to 
improve patient health, with increased functional capacity and decreased disease activity 
reported (Metsios et al., 2008). In addition, our group has recently shown that individualised 
exercise improved CVD risk factors (Stavropoulos-Kalinoglou et al., 2012) and endothelial 
function (Metsios et al., 2013) in RA patients.  
It is now well established that exercise can stimulate an acute rise in oxidative stress 
(Turner et al., 2011; Bloomer et al., 2005). There is evidence in healthy populations that over 
a period of training, the repetitive stimuli of exercise-induced RONS mediate increases in 
mitochondrial biogenesis (Ristow et al., 2009) and antioxidant enzyme protein expression 
(Khassaf et al., 2003) that result in lower levels of oxidative stress. In addition, exercise 
training is associated with reductions in systemic markers of inflammation, such as IL-8 
(Trøseid et al., 2004) and C-reactive protein (Stewart et al., 2007), an acute phase protein 
implicated in atherosclerotic plaque development (Danesh and Pepys, 2009). 
Early studies assessing oxidative stress in exercising RA patients demonstrated that 
isolated knee extension contractions can increase ROS production and subsequent oxidation 
of synovial biomolecules (Zhang et al, 1993; Edmonds et al, 2001; Blake et al, 1989). 
However, only one previous studies has assessed the impact of whole body exercise on 
oxidative stress in RA (Rall et al. 2000). Rall et al, 2000 reported no changes in urinary DNA 
oxidation following 12 weeks of resistance exercise. To our knowledge, no studies have 
explored the impact of whole body aerobic exercise on oxidative stress in RA, either 
following a single bout of exercise or repeated bouts of exercise. The aim of this study was to 
assess plasma markers of oxidative stress in response to an acute bout of exercise in untrained 
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RA patients. In addition, the impact of 3 months of moderate intensity aerobic exercise on 
plasma markers of oxidative stress and inflammation were examined. 
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3.3. Methods 
3.3.1 Patients 
RA patients were recruited from the rheumatology outpatient clinics of the Dudley 
Group NHS Foundation Trust following ethical approval from the Black Country ethical 
committee. All procedures took place at Dudley Group NHS Foundation Trust and the trial 
was registered with the ISRCTN register (ISRCTN50861407). All patients gave their 
informed written consent and experimental procedures were in accordance with the 
declaration of Helsinki. Inclusion criteria were: RA according to the American College of 
Rheumatology (ACR) 1987 revised criteria (Arnett, 1988), a sedentary lifestyle (not engaged 
in structured physical activity within the last 6 months) and stable disease activity (no 
changes in disease-modifying antirheumatic drugs (DMARDs) or intra-venous (IV) and intra-
muscular (IM) steroids within the last 3 months). Exclusion criteria were: recent joint surgery 
or co-morbidity that would impact on the patient’s ability to undertake regular exercise 
(ACSM, 2005). Upon entry into the training study, patients were randomised into exercise 
and control groups as described previously (Stavropoulos-Kalinoglou et al., 2012; Metsios et 
al., 2013). 
 
3.3.2 Acute Exercise Study  
3.3.2.1 Acute Exercise Protocol 
All patients were required to visit the laboratory on two separate occasions. On the 
first visit, baseline assessments of heart rate, blood pressure, demographic and 
anthropometric data and disease activity were obtained. Patients then undertook an exercise 
tolerance test (ETT) to determine their cardiorespiratory fitness.  
On a separate day, after an overnight fast, a blood sample was taken from the 
antecubital vein of the arm by an indwelling catheter. Patients then undertook a single bout of 
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exercise at a heart rate that elicited 70% maximum oxygen consumption (VO2MAX) for 30-40 
minutes (Figure 3.1). Heart rate monitors (Polar S610i, Polar Electro Oy, Kempele, Finland) 
were used to confirm adherence to the exercise intensity. Patients performed 3 circuits, with 1 
minute of rest in-between each circuit. Each circuit consisted of 3-4 intervals, where patients 
were instructed to exercise for no more than 3-4 minutes per interval. Blood samples were 
taken before (baseline), immediately (post+0) and 30 minutes following exercise (post+30).  
All blood samples were centrifuged (3000 rpm at 8°C for 10 minutes) and plasma was stored 
at -80°C until further analyses. Due to complications with blood sample availability, data 
from the acute exercise study was available for only 12 of the 19 patients in the training study. 
 
 
 
Figure 3.1: A schematic of the acute exercise assessment. 
 
3.3.2.2. Exercise tolerance test 
Cardiorespiratory fitness was assessed by determining the VO2MAX of patients. All 
patients were assessed on a treadmill (HP Cosmos, sports & medical gmbh, Nussdorf-
Traunstein, Germany). A breath-by-breath system (Metalyzer 3B, CORTEX Biophysik 
30-40mins @ 70% VO2max
Baseline Post+0 Post+30
Blood SampleKey: Approximately 1 
Minute Rest Interval
1 Circuit
(3-4 exercises; 3-4 
minutes per exercise)
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GmbH, Leipzig, Germany) was used for continuous measurement of oxygen uptake (VO2), 
lung ventilation and cardiorespiratory parameters. In addition, heart rate was monitored 
during the test. After familiarisation, an incremental test (4-7km/h), with increasing 
inclination of the treadmill by 1% every 30 seconds was used until patients reached volitional 
exhaustion. VO2MAX was corrected for the weight of the patients and expressed in ml.kg-
1min-1. 
 
3.3.2.3 Analytical Procedures 
Blood Assessments 
Haemoglobin (g/dL) and haematocrit (%) were assessed to calculate plasma volume changes 
as a result of exercise (Kargotich et al., 1997) (Coulter Analyser, Beckman-Coulter, High 
Wycombe, UK). All reagents purchased from Sigma unless stated (Sigma Aldrich, Dorset, 
UK). 
 
Protein Carbonylation (PC) 
PC was assessed by ELISA (Buss et al., 1997; Carty et al., 2000) in order to quantify the 
degree of protein oxidation in plasma samples.  Samples were diluted in coating buffer 
(50mM sodium carbonate, pH=9.2) to a concentration of 0.05mg/ml.  Samples and standards 
(50µl) were added in triplicate to a 96 well NUNC maxisorb microtitre plate for 1 hour at 
room temperature.  Bound protein was then incubated in the dark for 1 hour at room 
temperature with 2, 4-dinitrophenylhydrazine (DNPH) (1mM, in 2M HCl).  All wells were 
then blocked (200µl) with TBS Tween (0.1%) overnight at 4°C.  Wells were incubated with 
monoclonal mouse anti-DNP antibody (50µl, 1:1000) for 2 hours at room temperature, 
followed by peroxidase conjugated rat anti-mouse IgE conjugated HRP (50µl, 1:5000, AbD 
Serotec, Oxford, UK) for 1 hour at room temperature.  All steps were followed by three 
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washes to the 96 well plate using TBS Tween (0.05%).  Substrate (0.5M Citrate phosphate 
buffer (10mls, pH=5), hydrogen peroxide (8µl) and Ortho-Phenylenediamine tablet (2mg); 
50µl) was added to each well and the reaction stopped after 20-25 minutes with 2M sulphuric 
acid (50µl).  Each well was measured for absorbance at 490nm (Multiscan MS, Labsystems) 
and quantified using absorbance values of PC standards made in our lab (1.28-5.20 nmols/mg 
of protein). This method is detailed in section 2.3.8. Protein concentration was determined 
using the bicinchoninic assay method (Smith et al., 1985), described in section 2.3.8. 
 
Lipid Hydroperoxides (LOOH) 
LOOH concentrations were assessed using a spectrophotometric assay (El-Saadani et al., 
1989).  Samples and a blank standard (10μl) were added to a 96 well microtitre plate in 
triplicate.  Reagent mix (100µl, 0.2M Potassium phosphate (pH=6.2), 0.12M potassium 
iodide, 0.15mM sodium azide, Triton X (2g/l), alkylbenzyldimethlammonium (0.1g/l), 10µM 
ammonium molbdate and HPLC grade water (to make total volume 100mls)) was added for 
30 minutes at room temperature, away from light on a plate shaker. The plate was read at 
340nm (Multiscan MS, Labsystems), concentration of lipid peroxides (μmol/l) determined 
using the Beer-Lambert Law (extinction co-efficient ε340 = 24600 M-1cm-1) and adjusted for 
changes in plasma volume (Kargotich et al., 1997). 
 
Total Antioxidant Capacity (TAC) 
TAC was assessed using the Ferric Reducing Ability of Plasma (FRAP) assay (Benzie and 
Strain, 1996).  Plasma samples (10 µl per well) and standards (ascorbic acid, 0-1000 µM; 10 
µl) were added in triplicate to a flat bottomed 96 well plate.  FRAP reagent (300mM sodium 
acetate (pH=3.6), 160mM 2, 4, 6- tripyridyltriazine and 20mM ferric chloride (FeCl3); 300µl) 
was added to each well and left to incubate for 8 minutes at room temperature, then 
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absorbances read at 650nm. TAC values were obtained using absorbance values of known 
ascorbic acid concentrations (0-1000µM), expressed as µM of antioxidant power relative to 
ascorbic acid (McAnulty et al., 2005) and adjusted for changes in plasma volume (Kargotich 
et al., 1997).  
 
Total Nitric Oxide Metabolites (NOx) 
The Griess assay was used to quantify NOx in plasma samples (Miranda et al., 2001; 
Moshage et al., 1995).  Samples (100µl) were diluted with HPLC grade water (375µl) and 
zinc sulphate (25µl, 300mg/ml) to give a concentration of approximately 15mg/ml.  Samples 
were vortexed and then centrifuged at 10,000g for 20 minutes (10°C).  Supernatants and 
standards (100µl) were added to a 96 well microtitre plate, and 100µl vanadium (III) chloride 
(8mg/ml) then added.  Thorough mixing was ensured to fully reduce plasma nitrate to nitrite. 
Sulphanilamide (50µl,2%) and N-(1-naphthyl) ethylendiamine dihydrochloride (50µl,0.1%) 
were then rapidly added to each well.  Plates were incubated for 30 minutes at 37°C, 
absorbances read at 540nm and compared with values of known nitrite concentrations (0-
100μM). Values were adjusted for changes in plasma volume (Kargotich et al., 1997). 
 
3.3.2.4 Assessments 
Demographic & anthropometric assessments 
Demographic data was collected by questionnaire. Height and weight were measured to the 
nearest 0.5cm (Seca 214 Road Rod) and 0.5kg (B (Tanita C-418 MA Segmental Body 
Composition Analyser, Tanita Corporation, Tokyo, Japan) respectively, and body mass index 
(BMI) was subsequently calculated. 
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Pulse Rate & Blood Pressure 
Pulse rate and Blood pressure (BP) was assessed following at least 5 minutes of rest, on the 
right arm with the patient in a seated position.  Reported values represent the mean of three 
readings taken at 5 minute intervals.  
 
RA assessments 
Clinical disease activity (DAS28) was assessed in accordance with a validated 28-joint count 
system (Prevoo, 1995).  
 
3.3.3. Exercise Training Study 
3.3.3.1. Baseline Assessments 
Baseline demographic, anthropometric and disease related measures, as well as 
cardiorespiratory fitness were assessed as described in the acute exercise study. As before, a 
fasted blood sample was taken from the antecubital vein of the arm. Serum and plasma (after 
centrifuging at 3000 rpm at 8°C for 10 minutes) were stored at -80°C until further analysis. 
Triglycerides, cholesterol and high density lipoprotein cholesterol (HDL-C) were analysed 
immediately using a Vitros 5.1 FS Chemistry System.  
 
3.3.3.2 Exercise Training Protocol 
The exercise training protocol is described in detail elsewhere (Stavropoulos-
Kalinoglou et al., 2012; Metsios et al., 2013). As described above, 12 patients from the acute 
exercise study continued into the exercise training study, alongside 7 additional RA patients. 
Briefly, exercise training commenced within two weeks of the ETT. Patients in the control 
group were given advice on the benefits of exercise throughout the same period. Whenever 
possible, patients in both groups and their managing consultants were asked to avoid changes 
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to DMARDs or IV and IM steroid use. Patients in the exercise group undertook three sessions 
per week, two semi-supervised by a qualified exercise physiologist and one session 
performed in their own time. In each session, patients worked at a heart rate that elicited 70% 
VO2MAX (Figure 3.2). Heart rate monitors (Polar S610i, Polar Electro Oy, Kempele, Finland) 
were attached to the sternum of patients during each session to confirm adherence to the 
prescribed exercise intensity. Depending on patient preference and the physiologists’ 
assessment of the perceived ability of the patient, the exercise prescription used a treadmill, 
cycle, hand or rowing ergometer. Patients performed 3 circuits per session with 1 minute of 
rest in-between each circuit. Each circuit consisted of 3-4 intervals, where patients were 
instructed to exercise for no more than 3-4 minutes per interval (total exercise 30-40 minutes). 
Following the 3 month period, all baseline assessments were repeated in both groups (Figure 
3.2).  
 
 
 
Figure 3.2: A schematic of the 3 month protocol for exercise and control groups. 
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3.3.3.3 Analytical Procedures 
 
PC, LOOH, TAC and NOx were assessed as in the acute exercise study. All reagents 
purchased from Sigma unless stated (Sigma Aldrich, Dorset, UK). 
 
Free & Protein Bound 3-Nitrotyrosine 
Free and protein-bound plasma 3-nitrotyrosine (3-NT) was quantified using High 
Performance Liquid Chromotography with electrochemical detection  (HPLC-EC), based on 
the method described by Maruyma et al. (1996). Mobile phase (Citric Acid (50mM, pH=3.1), 
Phosphoric Acid (50mM), Octane Sulphonic Acid (100 mg/l), Ethylenediaminetetraacetic 
acid (EDTA) (40 mg/l) and methanol (5%)) was made fresh daily and set at 1.0 ml/min flow 
rate (applied voltage = 990mV). Total free and bound 3-nitrotyrosine was determined by 
diluting samples to 1mg/ml in Calcium Chloride (10mM) and hydrolysed with Pronase 
(20µg/L). Samples were spiked with known concentrations of synthetic 3-NT (10µM) and 
loaded (20μl) onto a C18 column (Phenomenex, Luna 3μM, C18 (2) 100A, 150x4.60mm). In 
addition, daily quality controls were run (3-NT, 10µM) and used for the calibration of the 
HPLC, alongside weekly standard curves (0-20 µM) for subsequent quantification of plasma 
3-NT (see figure 3.3).  Levels of 3-nitrotyrosine were calculated by subtracting the peak area 
(mV*min) of the synthetic 3-nitrotyrosine standard (10μM) from the peak area of the spiked 
sample (plasma 3-NT + 10 µM standard) (example chromatograms, figure 3.4). Samples 
were analysed in duplicate. 
 
 
 
 
 
88 
 
 
Figure 3.3  3-Nitrotyrosine standard curve (0 – 20 µM) 
 
 
 
 
Figure 3.4  Example chromatograms from HPLC-EC analysis of synthetic and plasma 3-
NT. The area (mV*min) from the synthetic 10μM 3-NT standard (3.4 A) was subtracted from 
the combined area of the plasma 3-NT and 10 µM spike (3.4 B). 
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Catalase Enzyme Activity 
Peroxidatic activity of Catalase was measured in plasma (diluted 1:1 with sample buffer 
[25mM potassium phosphate, pH = 7.5, 1mM EDTA and 0.1%BSA]), using a commercially 
available assay kit according to manufacturer instructions (Cayman Chemical). In brief, 
samples were incubated with methanol, in presence of hydrogen peroxide, and formaldehyde 
formation measured as an indicator of enzyme activity. After addition of a chromogen 
(purpald), cell absorbance’s were measured spectrophotometrically at 540nm and compared 
with absorbances of standards of known formaldehyde concentration (0-75µM). 
 
C-Reactive Protein 
Serum concentrations of CRP (mg/dL) were obtained using the Vitros® 5.1 FS Chemistry 
system by a clinical biochemist at Dudley hospital. In brief, samples were added to a slide 
alongside phosphorylchoine bound polystyrene polymer beads, which can bind CRP.  A 
monoclonal anti-CRP antibody and lueco detection dye were then added to the slide and the 
reflection density of the dye and CRP-antibody complex was proportional to amount of CRP 
in the sample. 
 
Interleukin-8 (IL-8) 
Plasma concentrations of IL-8 were determined using a commercially available ELISA kit, 
according to manufacturer instructions (Sanquin, PeliKine).  Briefly, samples (diluted 1:5 
with dilution buffer [Sanquin]) were incubated with a monoclonal antibody derived against 
IL-8 and then substrate solution (12ml substrate buffer, 0.11M acetate buffer, pH=5.5; 200µl 
3,5,3',5'-tetramethylbenzidine, 6mg/ml in dimethyl sulfoxide; 12µl hydrogen peroxide, 3%) 
added and absorbances read at 450nm.  Values were obtained from a linear standard curve of 
known IL-8 concentrations (0-240pg/ml). 
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3.3.3.4. Statistical Analysis 
Statistical analyses were performed using SPSS (PASW Statistics, release 18.0, SPSS 
Inc., Chicago, IL, USA). Measurements taken in the acute exercise study were analysed by 3 
time (pre, post+0 and post+30) repeated measures analyses of variance (ANOVA). In the 
training study, potential baseline differences in demographic, fitness, disease activity, 
inflammation or oxidative stress variables between the exercise and control group were 
assessed using independent t-tests. Changes as a result of exercise training were assessed by 2 
group (exercise, control) by 2 time (baseline, 3 months) repeated-measures ANOVA. The 
Kolmogorov Smirnov test was used to test for normally distributed data at all timepoints. 
Data was log transformed where appropriate (Log10). Statistical significance was accepted at 
the p<.05 level. 
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3.4. Results 
3.4.1. Acute Response to Exercise 
3.4.1.1. Oxidative stress response to exercise 
Table 3.1 describes the characteristics of the patients in the acute exercise study. 
Changes in response to exercise of NOx, TAC, LOOH and PC (before [baseline], 
immediately [post+0] and 30 minutes following exercise [post+30]) are shown in Figure 3.3 
(A-D). Exercise caused a significant increase in NOx (p=.040) and PC (p=.033). Post hoc 
analyses revealed that PC was significantly different from pre-exercise values post+30 
(p=.002). No statistical differences were observed in TAC or LOOH in response to exercise 
(p’s>.05). 
 
Table 3.1: Mean (SD) patient characteristics in the acute exercise study. 
Patient Characteristics (N=12) 
Age (yrs) 56 (11) 
Weight (kg) 78.46 (14.23) 
BMI (kg.m-2) 28.61 (4.97) 
VO2MAX (ml.kg-1min-1) 25.31 (5.31) 
Resting Heart Rate (bpm) 74.3 (10.95) 
Mean Arterial Pressure (mmHg) 97.83 (6.93) 
Disease Activity Scores 
(DAS28) 
2.98 (1.17) 
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Figure 3.5: Acute oxidative stress response to exercise in RA. Nitric oxide metabolites (A), 
Total antioxidant capacity (B), Lipid hydroperoxides (C) & Protein carbonylation (D). Data 
are means ± standard error, *p < 0.05 significantly different from baseline. #p < 0.05 
indicates a main effect of time. 
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3.4.2. Exercise Training Study 
3.4.2.1. Baseline measures 
Characteristics of the patients in the exercise and control group at baseline are 
reported in Table 3.2. There were no group differences in any of the variables reported in 
Table 3.2 (Independent t-test).  
 
Table 3.2: Mean (SD) patient characteristics in the exercise training study at baseline. 
Patient Characteristics Control (N=7) Exercise (N=12) 
Age (yrs) 53 (12) 57 (9) 
Weight (kg) 78.5 (13.04) 79.03 (15.28) 
BMI (kg.m-2) 28.30 (4.16) 29.08 (6.63) 
Disease Duration (yrs) 7 (4) 7 (7) 
VO2MAX (ml.kg-1min-1) 25.01 (4.58) 24.45 (4.98) 
Resting Heart Rate (bpm) 79.14 (10.39) 70.33 (10.47) 
Mean Arterial Pressure 
(mmHg) 
92.71 (9.72) 96.75 (5.81) 
 
3.4.2.2. Markers of disease activity, aerobic fitness, nitric oxide metabolism and 
cardiovascular risk factors in response to exercise training 
The effect of exercise on DAS28, VO2MAX and cardiovascular risk factors are shown 
in Table 3.3. DAS28 and VO2MAX were unchanged in the control group, whereas DAS28 
decreased (interaction effect, p=.004) and VO2MAX increased (interaction effect, p=.001) in 
the exercise group. No changes were observed in either group in weight, BMI, or lipid levels 
(p’s>.05).  
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Table 3.3: Mean (SD) disease activity, aerobic fitness, nitric oxide metabolites & 
cardiovascular risk factors values at baseline and following 3 months of training. 
*p < .05 significantly different from baseline. 
 
3.4.2.3. Markers of oxidative stress in response to exercise training 
The effects of exercise on markers of oxidative stress are shown in Table 3.4. No 
changes were observed in catalase enzyme activity, logLOOH, PC or logTAC in either the 
control or exercise groups (time and interaction effects, p’s>.05). A non-significant increase 
in TAC was observed in the exercise group only, but this did not reach statistical significance 
(interaction effect, p=.113). However, a significant group x time interaction effect was found 
for levels of free and bound 3-nitrotyrosine (p=.027). Post hoc analyses revealed that 3-
nitrotyrosine was unchanged in the control group, whereas it was decreased in the exercise 
group (Figure 3.4).  
 
 Control Exercise 
 Baseline 3 Months Baseline 3 Months 
Disease Activity (DAS28) 2.43 (0.84) 2.79 (0.68) 3.47 (1.17) 2.88 (0.76)* 
VO2MAX (ml.kg-1.min-1) 25.01 (4.58) 22.77 (3.45) 24.45 (4.98) 27.10 (4.51)* 
Weight (kg) 78.5 (13.04) 79.11 (13.10) 79.03 (15.28) 78.01 (14.69) 
BMI (kg.m-2) 28.30 (4.16) 28.53 (4.25) 29.08 (5.63) 28.70 (5.40) 
NOx (µM) 25.97 (12.43) 29.71 (15.04) 22.71 (12.18) 25.29 (12.96) 
Cholesterol (mg/dL) 4.73 (1.08) 4.76 (1.06) 4.97 (1.15) 4.88 (1.23) 
Triglycerides (mg/dL) 1.33 (0.63) 1.27 (0.69) 1.41 (0.50) 1.38 (0.95) 
HDL-C (mmol/L) 1.59 (0.36) 1.61 (0.23) 1.34 (0.47) 1.34 (0.40) 
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Table 3.4: Mean (SD) markers of oxidative stress at baseline and in response to 3 months 
training in RA patients. 
*p < .05 (repeated measures ANOVA) is a decrease compared with baseline values. 
Interquartile range (IQ) is reported for log transformed data. 
 
3.4.2.4. Markers of inflammation in response to exercise training 
The effects of exercise on markers of inflammation are shown in Table 3.5. No changes were 
observed in IL-8 or logCRP in either the exercise and control groups. 
 
 Control Exercise 
 Baseline 3 Months Baseline 3 Months 
Protein carbonyls 
(nmol/mg protein) 
1.79 (0.28) 1.82 (0.15) 1.78 (0.13) 1.76 (0.25) 
Lipid Hydroperoxides 
(nM) 
8.69 (5.56) 
IQ = 10.35 
9.01 (6.39) 
IQ = 11.83 
7.04 (6.63)  
IQ = 6.47 
5.07 (5.12) 
IQ = 4.74 
Total free and bound 3-
Nitrotyrosine (µM) 
0.947 (0.75) 1.626 (1.27) 2.175 (1.78) 1.101 (0.93)* 
Catalase activity 
(nmol/min/ml) 
46.33 (13.17) 50.10 (12.76) 44.21 (14.76) 46.30 (6.94) 
Total antioxidant capacity 
(µM: equivalent to 
ascorbic acid) 
763.81 (67.81) 
IQ = 64.44  
763.81 (160.67) 
IQ = 173.33 
812.12 (108.99) 
IQ = 202.22 
926.06 (242.38) 
IQ = 253.33 
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Table 3.5: Mean (SD) markers of inflammation in response to 3 months training in RA 
patients. 
Interquartile range (IQ) is reported for log transformed data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Control Exercise 
 Baseline 3 Months Baseline 3 Months 
Interleukin-8 (pg/ml) 7.12 (±2.13) 7.60 (±2.77) 6.52 (±1.86) 6.16 (±1.06) 
CRP (mg/L) 
3.43 (±0.43) 
IQ = 0.5 
5.43 (±1.09) 
IQ = 3 
8.17 (±1.75) 
IQ = 9 
3.92 (±0.53) 
IQ = 2 
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3.5. Discussion 
This is the first study to examine the effects of both an acute bout and repeated whole 
body aerobic exercise sessions on markers of oxidative stress in untrained patients with RA. 
Plasma PC and NOx increased in response to a single bout of moderate intensity exercise 
(Figure 3.3). Following 3 months of exercise training at the same intensity as the acute bout, 
we observed a decrease in plasma 3-NT. PC, LOOH, TAC or CAT remained unchanged post-
training when compared to pre-training values (Table 3.4). In line with previous studies, 
disease activity was reduced and aerobic fitness increased in the exercise training group only 
(Table 3.3).  
Acute moderate intensity exercise (≈60-70% VO2MAX) has previously been shown to 
cause an increase in PC (Bloomer et al., 2007), LOOH (Turner et al., 2011) and TAC 
(Berzosa et al., 2011) in young healthy males. The current study reports an increase in PC, 
however no significant changes in LOOH or TAC following a single exercise bout in RA 
patients. Protein carbonylation represents a global, rather than specific, oxidative 
modification to proteins, which can be indicative of both targeted proteolytic degradation and 
post translational modification (Dalle-Donne et al., 2006). Interestingly, the degree (+/- 
nmol/mg protein) of change in PC relative to baseline in the current study was comparable to 
that reported in a previous study of similar intensity and duration (70% VO2MAX, 30 minutes) 
in young, healthy men and women (Bloomer et al., 2007). Antioxidant capacity may decrease 
during exercise as antioxidants quench radicals that are released, but studies generally report 
increases in antioxidant capacity in healthy subjects (Turner et al., 2011), as soluble 
antioxidants are mobilised from vessel walls (Gleeson, M., Robertson, J.D., Maughan, 1987). 
In RA, there is evidence that TAC is lower in comparison to age-matched controls at rest 
(Sarban et al., 2005). In the current study, TAC increased thirty minutes following exercise, 
relative to baseline (+11.4%), but this increase did not reach statistical significance. 
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Nevertheless, these data collectively indicate that a single bout of moderate intensity exercise 
caused a transient change in markers of oxidative stress comparable with those observed in 
healthy populations. 
Following three months of regular moderate intensity exercise, a decrease in total free 
and bound plasma 3-NT was observed. Given that no alterations were observed in NOx, CRP 
or IL-8 following 3 months of exercise training (Table 3.5), it is unlikely that this decrease 
was driven by altered NO production, which is sometimes seen following exercise training 
where systemic inflammation is perturbed (Gielen et al., 2003). Similar decreases in LOOH, 
PC, TAC and CAT were not observed following 3 months of training, however, it must be 
noted that these levels at baseline were low in comparison to previous studies in RA (Seven 
et al., 2008) and studies in our laboratory in healthy cohorts (Turner et al., 2011). While this 
may be a reason why decreases in global markers of oxidative stress were not observed, the 
decrease in 3NT may represent a specific and functional post-exercise protein modification. 
Given that previous evidence has highlighted an important role for 3NT in linking oxidative 
stress with vascular pathology (Griffiths et al., 2006), this finding warrants further study. 
There is limited data available assessing the significance of acute increases in 
oxidative stress in response to exercise in clinical populations. Whilst emerging evidence in 
healthy populations strongly suggests that repeated exercise-induced increases in oxidative 
stress are adaptive (Ristow et al., 2009), a theoretical ‘threshold’ may exist, whereby 
exercise-induced RONS production could compromise redox status, and be detrimental to 
health  (Goto et al., 2007). Indeed, previous studies in patients with heart disease have 
reported an exaggerated oxidative stress response following an exhaustive bout of exercise 
when compared to age-matched controls (Nishiyama et al., 1998; Avogaro et al., 1986). In 
the context of RA, RONS are thought to play a significant role in progressive joint 
degradation and risk for CVD (Mapp et al., 1995; Winrow et al., 1993). This is the first study 
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to demonstrate that a period of moderate intensity training does not exacerbate basal levels of 
oxidative stress in RA patients with stable disease activity. In conjunction with data from the 
acute exercise study, transient increases in oxidative stress following moderate intensity 
exercise may be beneficial, providing further support for the use of moderate intensity 
exercise in RA.  
This study is not without limitations. Firstly, an age-matched non-RA control group 
was not used in the acute exercise study to compare the differences in the oxidative stress 
response to exercise between non-RA and RA patients. However, the results presented clearly 
show that exercise did not stimulate an exaggerated oxidative stress response to exercise in 
RA, when compared to other studies assessing similar outcome measures in healthy 
populations (Turner et al., 2011; Bloomer et al., 2007). In the exercise training study, the 
sample size used was small and the disease activity of the RA patients was relatively low. 
Although statistically significant baseline differences in markers such as 3-NT and CRP were 
not observed between exercise and control groups, this may be attributable to low statistical 
power. However, in the context of training-induced reductions in plasma 3-NT, it must be 
noted that 9 of the 12 subjects in the exercise group demonstrated a marked reduction in total 
and bound 3-NT, supporting a robust finding. Nevertheless, with no other data available, to 
our knowledge, exploring oxidative stress in response to whole body aerobic exercise in RA, 
these preliminary results are perhaps applicable only to patients with stable disease activity. 
Changes to patient medication were not prevented in this study, in either the exercise or 
control group, however no patients reported any changes throughout the 3 month period.  
The results of the current study provide data showing that oxidative stress is increased 
in response to a single bout of moderate intensity exercise in RA patients. Three months of 
moderate intensity exercise training increased aerobic fitness, decreased disease activity and 
decreased plasma protein nitration. All other markers of oxidative stress and inflammation 
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were unchanged following exercise training, indicating that exercise did not cause prolonged 
or significant oxidative stress. These data demonstrate that transient exercise-induced 
increases in oxidative stress are not harmful in RA patients with stable disease activity, but in 
concurrence with studies in healthy populations, may be adaptive. Further research is 
required to clarify this in RA. 
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Chapter Four 
4. Impact of low volume high intensity interval exercise on 
markers of oxidative stress 
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4.1. Abstract 
Purpose: Low volume, high intensity interval training (LV-HIIT) is a time and energy-
efficient exercise strategy producing similar beneficial physiological effects to those of 
steady state exercise. Acute oxidative stress and inflammation are potential mediators of the 
adaptations to exercise, however the oxidative stress and inflammatory responses to a bout of 
LV-HIIT are unknown.  
Methods: Untrained healthy males (n=10, mean ± SD: age 22 ± 3 yrs; VO2MAX 42.7 ± 5.0 
ml/kg/min-1) undertook three exercise bouts: a bout of LV-HIIT (10*1 minute 90% VO2MAX 
intervals) and two energy-matched steady-state cycling bouts at a moderate (60% VO2MAX; 
27 min, MOD) and high (80% VO2MAX; 20 min, HIGH) intensity on separate days. Blood 
samples were taken before (baseline), during the last minute of exercise (exercise) and 30 
minutes following exercise (post+30). Markers of oxidative stress and inflammation were 
assessed, in addition to lymphocyte number, and adrenaline. Blood pressure and heart rate 
was measured continuously.   
Results: HIGH caused the greatest lymphocytosis, adrenaline and cardiovascular response 
(p’s<.05). In all exercise bouts, lipid hydroperoxides (LOOH) and total antioxidant capacity 
(TAC) were significantly increased during and post+30, relative to baseline and during 
exercise respectively (LOOH (nmol/ml plasma): MOD +0.36; HIGH +3.09; LV-HIIT +5.51 
and TAC (µM): MOD +189.44; HIGH +134.72; LV-HIIT +102.24). IL-6 and IL-10 
increased post+30 in HIGH and LV-HIIT only.  
Conclusions: HIGH was the greatest physiological stressor of the three bouts of exercise 
compared in the present study. LV-HIIT was more comparable to HIGH when markers of 
oxidative stress and inflammation were assessed. LV-HIIT and HIGH, but not MOD 
stimulated an anti-inflammatory response to exercise.   
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4.2. Introduction 
Reactive oxygen and nitrogen species (RONS) are by products of normal cellular 
metabolism that regulate cellular signalling and homeostasis. Oxidative stress is a state 
whereby RONS exceed endogenous and exogenous antioxidants systems, resulting in the 
progressive oxidation of molecules (proteins, lipids and DNA) within the body. Chronic 
oxidative stress is widely implicated with the ageing process (Harman, 1956) and a range of 
human diseases (Aldred, 2007). While exercise training may represent a valuable means of 
reducing chronic oxidative stress in some populations (Donato et al., 2010), an acute bout of 
steady state exercise is known to cause oxidative stress (Michailidis et al., 2007). It is now 
widely accepted that the increase in RONS that follows an acute bout of exercise can 
facilitate a host of beneficial adaptations within skeletal muscle (Gomez-Cabrera et al., 2008b; 
Ristow et al., 2009). We recently suggested that there is a reciprocal relationship between 
oxidative stress and inflammation (Wadley et al., 2012) and there is now strong evidence to 
suggest that interleukin (IL)-6 can regulate substrate metabolism (Febbraio et al., 2004) and 
stimulate anti-inflammatory cytokines such as IL-10, following exercise (Fischer, 2006). 
However, the influence of exercise modality on markers of oxidative stress and inflammation 
remain incompletely understood.  
The most frequent barrier to participation in regular physical exercise within the 
general population is a perceived ‘lack of time’ (Stutts, 2002). The American College of 
Sports Medicine guidelines recommend up to 150 minutes of moderate intensity exercise per 
week (ACSM, 2005). High intensity interval training (HIIT) is defined as short, intense bursts 
of physical activity, combined with rest or low intensity intervals (Burgomaster et al., 2008). 
There is ample evidence to suggest that HIIT is equally effective in improving metabolic 
(Burgomaster et al., 2008), physiological (Wisløff et al., 2007) and vascular health (Cocks et 
al., 2012) as traditional steady-state exercise training, but with a reduced time commitment. 
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Modified HIIT protocols (Low volume HIIT (LV-HIIT)) have been developed for individuals 
not wishing to, or who are unable to engage in extremely demanding short bursts of high 
intensity physical activity (Gibala et al., 2012; Wisløff et al., 2007). LV-HIIT has been shown 
to increase markers of muscle metabolism (Hood et al., 2011) induce increases in VO2 peak, 
(Rognmo et al., 2004) and improve endothelial function (Wisløff et al., 2007).  
There is some evidence to suggest that the magnitude of increase in RONS (Bailey et 
al., 2004) and cytokines (Ostrowski et al., 2000) in response to exercise is intensity dependent, 
and given the role of RONS in exercise adaptation it is important to characterise the 
magnitude of this response. Recent evidence has indicated that LV-HIIT can induce an 
increase in plasma lipid oxidation and antioxidant enzyme activity immediately following 
exercise (Fisher et al., 2011). To our knowledge, there are no studies to date that characterise 
the response of oxidative stress and inflammation to LV-HIIT in the context of steady state 
exercise. Further, no studies have compared these changes with other physiological responses 
(cardiovascular, immune and hormonal markers). The aim of this pilot study was to compare 
plasma markers of oxidative stress and inflammation in response to LV-HIIT, high and 
moderate intensity steady state exercise bouts in a small sample of untrained males. Changes 
in total lymphocyte number, plasma adrenaline, heart rate and blood pressure were also 
assessed. We tested the hypothesis that LV-HIIT will elicit a significantly greater increase in 
oxidative stress and inflammation than moderate intensity steady state exercise.  
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4.3. Methods 
4.3.1. Participants 
Ten healthy, untrained (defined as VO2MAX < 50kg/ml/min-1) males (mean ± SD: age 
22 ± 3 yrs; body mass index 24.0 ± 3.1 kg/m2; VO2MAX 42.7 ± 5.0 ml/kg/min-1) took part in 
three separate exercise bouts. All participants gave their informed written consent and the 
investigation was approved by the Science and Technology ethical review committee at the 
University of Birmingham. Participants were non-smokers and excluded if they had ingested 
vitamin supplements or anti-inflammatory drugs in the two weeks prior to the first laboratory 
visit. In addition, subjects were required to abstain from foods high in dietary nitrate (beetroot, 
lettuce, spinach and processed meats) at least two days prior to each experimental session. In 
addition, participants were required to refrain from any strenuous physical activity or 
consumption of alcoholic beverages in the 48 hours prior to testing sessions. 
 
4.3.2. Preliminary Assessments 
Participants undertook all bouts in the School of Sport, Exercise and Rehabilitation 
Sciences at the University of Birmingham. All exercise bouts took place on an 
electromagnetically braked cycle ergometer (Lode Excalibur Sport, Groningen, Netherlands). 
Height and weight was recorded (Seca Alpha, Hamburg, Germany) and questionnaires 
administered for demographic and health screening purposes (Fisher and White, 1999). 
Cardiorespiratory fitness was assessed by determining the maximum oxygen consumption 
(VO2MAX) of the participant and expressed relative to body weight (ml.kg-1min-1). A breath-
by-breath system (Oxygon Prx, Jaeger, Wuerzberg, Germany) was used for continuous 
measurement of oxygen uptake and heart rate was monitored using a Polar Vantage heart rate 
monitor (Polar Vantage, Kempele, Finland). After a 3 minute warm up at 30 Watts, 
participants undertook an incremental exercise test to exhaustion, whereby workload 
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increased 30 Watts every minute until volitional exhaustion. Participants were asked to 
maintain a constant pedal rate and encouragement was given by an experimenter. A 
respiratory exchange ratio (VCO2/VO2) >1.10-1.15, plateau in participant oxygen 
consumption or a maximal heart rate >220 beats min-1 - age were all factors used to indicate 
VO2MAX and thus the termination of the test (Howley et al., 1995). 
 
4.3.3. Exercise Bouts 
One week after the first visit, participants returned to the laboratory following an 
overnight fast to undertake one of three randomised exercise bouts, each separated by at least 
one week (figure 4.1). Following a 30 minute period of rest, a catheter (Becton, Dickson & 
Company, Oxford, UK) was inserted into the antecubital vein of the forearm and a baseline 
blood sample taken (baseline). The catheter was kept patent through regular flushes with 
saline (0.9% NaCl). Participants then undertook a 5 minute warm up at a workload that 
elicited 40% of their maximum aerobic capacity, followed by the exercise bout at 60% 
VO2MAX for 27 minutes (Moderate, MOD), 80% VO2MAX for 20 minutes (HIGH) and ten 1 
minute stages at 90% VO2MAX, interspersed with nine 1 minute intervals at 40 % VO2MAX 
(LV-HIIT) (figure 4.1). MOD and HIGH were matched for total workload (kcal). A second 
blood sample (exercise) was taken during the last minute of each exercise bout to capture the 
peak physiological response and then 30 minutes following cessation of the exercise bout 
(post+30). At each time point, 5 ml of blood was drawn into a vacutainer tube containing 
potassium ethylene diaminetetraacetic acid (Becton, Dickson & Company, Oxford, UK) and 
centrifuged at 2800 rpm for 15 minutes at 4 °C.  Plasma was then extracted and stored at -
80 °C until further analysis. 
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Figure 4.1:  Study Protocol. Subjects completed an exercise test to exhaustion and then 
participated in 3 subsequent exercise bouts.  LV-HIIT was ten 1 minute stages at 90% 
VO2MAX, interspersed with nine 1 minute intervals at 40% VO2MAX. 
↓ Blood samples (baseline, exercise & post+30);   R, Rest;   W, Warm up (5min, 40% 
VO2MAX) 
 
4.3.4. Blood Assessments 
Blood samples were assessed for blood cell composition, specifically total peripheral 
blood lymphocytes. In addition, haemoglobin (g/dL) and haematocrit (%) were assessed to 
calculate plasma volume changes as a result of exercise (Bacon et al., 2004) (Coulter 
Analyser, Beckman-Coulter, High Wycombe, UK). All reagents purchased from Sigma unless 
stated (Sigma Aldrich, Dorset, UK). 
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Total Antioxidant Capacity 
TAC was assessed using the Ferric Reducing Ability of Plasma (FRAP) assay (Benzie 
and Strain, 1996).  Plasma samples (10 µl per well) and standards (ascorbic acid, 0-1000 µM; 
10 µl) were added in triplicate to a flat bottomed 96 well plate.  FRAP reagent (300 mM 
sodium acetate (pH=3.6), 160 mM 2, 4, 6- tripyridyltriazin  and 20mM ferric chloride (FeCl3); 
300 µl) was added to each well and left to incubate for 8 minutes at room temperature, then 
absorbance’s read at 650 nm. TAC values were obtained using absorbance values of known 
ascorbic acid concentrations, expressed as µM of antioxidant power relative to ascorbic acid 
(McAnulty et al., 2005) and adjusted for changes in plasma volume. The inter and intra-assay 
coefficients of variation (CV) are <3% and <1% respectively (Benzie and Strain, 1996). 
 
Lipid Hydroperoxides  
LOOH concentrations were assessed using a spectrophotometric assay (Görög et al., 
1991). Samples and a blank standard (10 μl) were added to a 96 well microtitre plate in 
triplicate. Reagent mix (100 µl, 0.2 M Potassium phosphate (pH=6.2), 0.12 M potassium 
iodide, 0.15 mM sodium azide, Triton X (2 g/l), alkylbenzyldimethlammonium (0.1 g/l), 10 
µM ammonium molbdate and HPLC grade water (to make total volume 100 ml)) was added 
for 30 minutes at room temperature, away from light on a plate shaker. The plate was read at 
340nm (Multiscan MS, Labsystems), concentration of lipid peroxides (μmol/l) determined 
using the Beer-Lambert Law (extinction co-efficient ε340 = 24600 M-1cm-1) and adjusted for 
changes in plasma volume. The inter-assay CV is 8.9% (El-Saadani et al, 1989). 
 
Nitrite and Nitrate (NOx metabolites)  
The Griess assay was used to quantify total nitric oxide metabolites (NOx) in plasma 
samples (Miranda et al., 2001).  Samples (100 µl) were diluted with HPLC grade water (375 
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µl) and zinc sulphate (25 µl, 300 mg/ml) to give a concentration of approximately 15 mg/ml. 
Samples were vortexed and then centrifuged at 10,000 g for 20 minutes (10 °C). Supernatants 
and standards (100 µl) were added to a 96 well microtitre plate in triplicate, and 100 µl 
vanadium (III) chloride (8 mg/ml) then added. Thorough mixing was ensured to fully reduce 
plasma nitrate to nitrite. Sulphanilamide (50 µl, 2 %) and N-(1-naphthyl) ethylendiamine 
dihydrochloride (50 µl, 0.1 %) were then rapidly added to each well. Plates were incubated 
for 30 minutes at 37 °C, absorbance read at 540 nm and compared with values of known 
nitrite concentrations (0-100 μM). Values were adjusted for changes in plasma volume. The 
inter and intra-assay CVs are 5.2% and 4.4% respectively (Asl et al, 2008). 
 
Interleukins   
Plasma concentrations of IL-6 were determined using a commercially available high-
sensitivity (HS) ELISA kit according to manufacturer instructions (R&D Systems, assay 
sensitivity: 0.11 pg/ml).  Briefly, samples (200 µl, diluted 1:1 with assay diluent) were 
incubated with a monoclonal antibody (200 µl) derived against IL-6, and then substrate (50 
µl) and amplifier (50 µl) solutions added to develop the colour change. Plates were washed 
intermittently to reduce non-specific binding. The reaction was stopped using 2 M sulphuric 
acid (50 µl) and absorbance’s read at 650nm. Values were then obtained from a linear 
standard curve of known IL-6 concentrations (0.156-10 pg/ml) and adjusted for changes in 
plasma volume. 
Plasma concentrations of IL-10 were determined using a commercially available HS 
ELISA kit, according to manufacturer instructions (R&D Systems, assay sensitivity: 0.17 
pg/ml).  Briefly, samples (250 µl, diluted 4:1 with assay diluent) were incubated with a 
monoclonal antibody (200 µl) derived against IL-10 and then substrate (50 µl) and amplifier 
(50 µl) solutions added to develop a colour change. Plates were washed intermittently to 
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reduce non-specific binding. The reaction was stopped using 2 M sulphuric acid (50 µl) and 
absorbance read at 490 nm. Values were then obtained from a linear standard curve of known 
IL-10 concentrations (0.78-50 pg/ml) and adjusted for changes in plasma volume. The inter 
and intra-assay CVs for HS IL-6 and IL-10 kits are 6.5% and 6.9% respectively (R&D 
Systems). 
 
Adrenaline 
Plasma concentrations of adrenaline were determined using a commercially available 
High-Sensitivity ELISA kit (assay sensitivity: 3 pg/ml), according to manufacturer 
instructions (Rocky Mountain Diagnostics Inc. USA). Briefly, adrenaline was extracted from 
plasma samples (750 µl) using a cis-diol-specific affinity gel, acylated and then derivitised 
enzymatically. Extracted plasma samples and controls (100 µl) were incubated with a 
monoclonal antibody (50 µl) derived against adrenaline and incubated overnight at 4 °C. The 
plate was then incubated with an enzyme conjugate (100 µl) and substrate (100 µl) to develop 
the colour change. Plates were washed intermittently to reduce non-specific binding. The 
reaction was stopped using 0.25 M sulphuric acid (100 µl) and absorbance’s read at 450 nm. 
Values were obtained from a standard curve of known adrenaline concentrations (0-1500 
pg/ml) and adjusted for changes in plasma volume. The intra-assay CV is 9.3% (Rocky 
Mountain Diagnostics Inc. USA). 
 
4.3.5. Sample size calculation and Statistical Analysis 
Power analyses using Gpower3 (Faul et al., 2007), with significance at .05 and power 
at .90, were conducted based upon results from previous studies and preliminary pilot work 
assessing markers of inflammation and oxidative stress following steady state exercise in 
sedentary young adults. Outcome measures of protein oxidation, IL-6 concentration changes 
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(2-fold) were used, based on previous studies from our laboratory. A sample size of 10 
participants was required to detect differences with an effect size of .24 (medium effect size).  
Statistical analyses were performed using SPSS (PASW Statistics, release 21.0, SPSS 
Inc., Chicago, IL, USA).  Kolmogorov–Smirnov tests were used to investigate normal 
distribution and differences between variables at baseline were assessed using one-way 
analyses of variance (ANOVA).  The physiological response to exercise was assessed by a 3 
exercise bout (MOD, HIGH, LV-HIIT) by 3 time (baseline, exercise, post+30) repeated-
measures ANOVA. Post hoc analysis of the interaction effects was performed by a test of 
simple effects by pairwise comparisons, with Bonferroni correction. Assessments of heart 
rate and blood pressure over time by area under the curve (AUC) were undertaken using one-
way repeated measures ANOVA. Pearson correlations were conducted to examine 
associations between adrenaline and total lymphocyte count. These analyses were performed 
separately for LV-HIIT and steady state bouts. Statistical significance was accepted at the 
p<0.05 level. 
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4.4. Results 
4.4.1. Oxidative Stress 
Lipid Hydroperoxides   
Figure 4.2A shows the response of plasma LOOH to the three different exercise bouts. 
LOOH significantly increased during exercise in all bouts (p=0.033). Thirty minutes 
following exercise, values had returned to baseline concentrations (p=0.023). No statistical 
differences were observed between bouts. Data was not normally distributed and 
subsequently log transformed prior to statistical analyses (Log10). 
 
Total Antioxidant Capacity  
Figure 4.2B shows the response of plasma TAC to the different exercise bouts. A 
trend was observed for a decrease in TAC during exercise in all bouts, however this did not 
reach statistical significance (p=0.161). Thirty minutes after exercise, TAC was significantly 
higher than during exercise (pairwise comparisons) in all bouts (p=0.004).  No statistical 
differences were observed between bouts. 
 
4.4.2. Inflammation 
Interleukins  
The effect of exercise on IL-6 concentrations can be seen in Figure 4.2C. IL-6 
increased during exercise (p=0.05) and post+30 (p=0.001) in all bouts. A significant group x 
time interaction effect was found (p=0.012) and pairwise comparisons indicated that the 
concentrations of IL-6 post+30 were significantly higher in HIGH compared to MOD 
(p=0.037). There were statistically significant increases in IL-6 post+30, relative to baseline 
(LV-HIIT: p=0.010; HIGH: p=0.016) and exercise (LV-HIIT: p=0.029; HIGH: p=0.048) in 
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LV-HIIT and HIGH. IL-6 increased post+30, relative to baseline in MOD (p=0.10). There 
were no statistical differences between the responses in LV-HIIT and HIGH. 
Figure 4.2D shows the response of IL-10 to the different exercise bouts. IL-10 was 
unchanged during exercise, however a significant increase was observed post+30 in HIGH 
and LV-HIIT (main effect of time: p=0.042). A significant group x time interaction effect 
was found (p=0.015) and pairwise comparisons indicated that the concentrations of IL-10 
post+30 were higher in HIGH than MOD (p=0.05). IL-10 increased post+30 relative to 
baseline (p=0.05) and during exercise (p=0.05) in LV-HIIT and HIGH respectively. There 
were no statistical differences between the response of LV-HIIT and HIGH. 
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Figure 4.2:  Changes in oxidative stress and inflammation in response to the three exercise 
bouts (n=10). (A) LOOH (B) TAC (C) IL-6 and (D) IL-10. Values are means ± standard error. 
* indicates significant differences during exercise, relative to baseline in all bouts (p<0.05). 
** indicates significant differences relative to during exercise in all bouts. # indicates 
significant differences between HIGH and MOD. Figure 2D: + indicates a significant 
difference between baseline and post+30 in LV-HIIT. ++ indicates a significant differences 
between exercise and post+30 in HIGH.  MOD (          ), HIGH (        ) and LV-HIIT 
(            ). 
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4.4.3. Other physiological measures 
Total Peripheral Blood Lymphocytes 
Figure 4.3A shows the response of total peripheral blood lymphocytes to the different 
exercise bouts. There was a significant lymphocytosis during exercise in all bouts (p<0.001), 
which returned to baseline values post+30 (p<0.001). A significant group x time interaction 
effect was found (p<0.001) and pairwise comparisons indicated that HIGH elicited a 
significantly greater lymphocytosis than both LV-HIIT (p=0.032) and MOD (p=0.002) 
during exercise. There were no statistical differences between the response during LV-HIIT 
and MOD. 
 
Adrenaline 
The effect of exercise on adrenaline concentrations can be seen in figure 4.3B. 
Adrenaline significantly increased during exercise in all bouts (p=0.04) and returned to 
baseline values post+30 (p=0.10). A significant group x time interaction effect was found 
(p<0.001) and pairwise comparisons indicated that HIGH elicited a significantly greater 
adrenaline response than both LV-HIIT (p=0.049) and MOD (p=0.037) during exercise. 
There were no statistical differences between the responses during exercise in LV-HIIT and 
MOD.  
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Figure 4.3:  Changes in total lymphocyte number (A) and plasma adrenaline (B) in response 
to the three exercise bouts (n=10). Values are means ± standard error. * indicates significant 
differences during exercise, relative to baseline (p<0.05). ** indicates significant differences 
relative to during exercise. # indicates significant differences compared to MOD and LV-
HIIT.  
 
Heart Rate and Blood Pressure 
The effect of exercise on baseline to peak heart rate, systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) during the exercise bouts is shown in figure 4.4. There 
was a significant increase in heart rate during exercise in all bouts (p<0.001), which returned 
to baseline values post+30 (p<0.001). A significant group x time interaction effect was found 
(p<0.001) and pairwise comparisons indicated that HIGH elicited a significantly greater heart 
rate response than MOD (p<0.001) during exercise. The magnitude of heart rate change 
during HIGH compared to LV-HIIT did not reach statistical significance during exercise 
(p=0.074). Thirty minutes following exercise, heart rate in both the LV-HIIT (p=0.001) and 
HIGH (p=0.002) was greater than MOD.  
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There was a significant increase in SBP during exercise in all bouts (p<0.001), which 
returned to baseline values post+30 (p=0.01). A significant group x time interaction effect 
was found (p=0.04) and pairwise comparisons indicated that LV-HIIT elicited a significantly 
greater peak SBP response than MOD (p=0.037). No differences were observed between the 
SBP response during HIGH and LV-HIIT. The SBP response thirty minutes following 
exercise in HIGH was significantly lower than MOD (p=0.003).  
Figure 4.5 indicates the changes in heart rate and blood pressure over time as assessed 
by the area under the curve (AUC). Total AUC for heart rate was significantly lower in MOD 
and LV-HIIT when compared to HIGH (MOD -31.8% (p<0.001) and LV-HIIT -31.1% 
(p=0.001)). A similar trend was observed for SBP, however only LV-HIIT was significantly 
lower than HIGH (MOD -33.5% (p=0.098) and LV-HIIT -29.1% (p=0.034)) (Figure 4.5). 
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Figure 4.4:  Cardiovascular response during the three exercise bouts (n=10). The percentage 
change in heart rate, systolic blood pressure and diastolic blood pressure from baseline to 
during the exercise bouts. Data are means ± standard error. * indicates significant differences 
relative to moderate bout (p<0.05).  
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Figure 4.5:  Area under the curve analysis of the cardiovascular response during the three 
exercise bouts (n=10). The change in heart rate (5A) and systolic blood pressure (5B) relative 
to baseline are shown. Data are means ± standard error. * indicates significant differences 
relative to HIGH (p<0.05).  
 
Nitric Oxide Metabolites 
Table 4.1 shows the response of plasma NOx to the different exercise bouts. There 
was a trend towards an increase in NOx both during exercise and post+30 in LV-HIIT only 
however this did not reach statistical significance. 
 
 
 
124 
 
Table 4.1:  NOx concentrations in response to the three exercise bouts (n=10). Values are 
means ± standard error. 
 
 
4.4.4. Correlation Analysis 
Correlation analysis indicated a significant positive correlation between the change in 
adrenaline and total lymphocyte count between baseline and during exercise in both HIGH 
(r=0.681, p=0.015) and LV-HIIT (r=0.851, p=0.001) bouts. No significant correlations were 
observed between the change in NOx and total lymphocyte count between baseline and 
during exercise in any of the bouts. 
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4.5. Discussion 
To our knowledge this is the first study to assess oxidative stress following a bout of 
LV-HIIT in comparison to steady state exercise. Our pilot findings are that LV-HIIT and 
steady state exercise caused a significant increase in markers of oxidative stress and 
inflammation. LV-HIIT was more comparable to HIGH than MOD when the magnitude of 
change in markers of oxidative stress was considered. The significant increases in LOOH 
concentrations observed in all bouts do indicate the presence of RONS following exercise.  
With compelling evidence that exercise-induced increases in oxidative stress are 
adaptive (Gomez-Cabrera et al., 2008a; Ristow et al., 2009), the peroxidation of lipids may 
stimulate adaptations such as structural remodelling of external cellular membranes and 
lipoproteins. The observed antioxidant response to all bouts of exercise is in agreement with 
previous studies (Berzosa et al., 2011; Turner et al., 2011). An increase in uric acid 
production from purine degradation (Cao and Prior, 1998), increases in vitamin C release 
from the adrenal glands (Gleeson, M., Robertson, J.D., Maughan, 1987) and an influx of cells 
with high cell-surface thiol content (Turner et al., 2011) could all be mechanisms behind this 
response. Collectively, these data are the first to indicate the LV-HIIT elicits a comparable 
oxidative stress response to steady state exercise. This pilot data could be used to power 
future larger-scale studies. 
IL-6 and IL-10 significantly increased in response to LV-HIIT and HIGH, indicating 
these exercise bouts were more effective than MOD in stimulating an anti-inflammatory 
response to exercise. Muscle contraction (Petersen et al., 2001), substrate availability 
(Febbraio et al., 2004) and adrenaline release (Steensberg et al., 2001) have all been linked 
with IL-6 transcription regulation and release into the circulation in response to exercise. 
Aside from the classical role of IL-6 to signal and facilitate the inflammatory response, there 
is also evidence to suggest that its release during exercise can regulate glucose uptake into 
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skeletal muscle (Febbraio et al., 2004) and transcription of anti-inflammatory cytokines such 
as IL-10 (Fischer, 2006). The present results are in support of these studies, with IL-10 
elevation seen thirty minutes following the increase in IL-6 in both LV-HIIT and HIGH. In 
the current study the largest IL-6 and IL-10 responses following exercise were in response to 
HIGH. Previous evidence has highlighted that exercise intensity may be the key factor 
governing IL-6 release when considering shorter bouts of steady state exercise under an hour 
(Ostrowski et al., 2000; Fischer, 2006). However, no studies to date have assessed the 
cytokine response to a bout of LV-HIIT. IL-6 and IL-10 increased following LV-HIIT, with 
the magnitude of this response appearing to sit in-between the two steady state bouts. Despite 
the higher peak intensity of LV-HIIT, the intermittent nature of the stimulus could have aided 
the clearance of both cytokines by the liver and kidneys (Febbraio et al., 2003) during the 
‘rest’ intervals. Nevertheless, these data indicate that LV-HIIT and short duration high 
intensity, but not moderate intensity steady state exercise, can elicit an anti-inflammatory 
response in untrained subjects. This is encouraging if the use of LV-HIIT is considered in 
patient populations given the reduced energy cost compared to steady state training.  
These data show that HIGH caused a significantly greater lymphocytosis and 
adrenaline response than MOD and LV-HIIT. Peak heart rate and SBP values were not 
different between LV-HIIT and HIGH. However, when changes in heart rate and SBP over 
time (AUC) were assessed as previously demonstrated (Fisher and White, 1999), LV-HIIT 
was more similar to MOD (figure 4.5). In line with previous work, intensity dependent 
increases in plasma adrenaline and total circulating lymphocyte number have regularly been 
observed (Krüger et al., 2008). However, despite higher peak intensity, LV-HIIT caused a 
lower adrenaline response and lymphocytosis than HIGH. Previous studies have observed up 
to a 35% drop in plasma adrenaline just 1 minute after cessation of the exercise stimulus 
(Zouhal et al., 2008), therefore, it may be possible that the lower response is due to clearance 
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of adrenaline in-between intervals. The correlation observed between the change in 
adrenaline and total lymphocyte count in response to exercise in both HIGH (r=0.681, 
p=0.015) and LV-HIIT (r=0.851, p=0.001) supports previous evidence that adrenaline can 
mobilise lymphocytes off the endothelial wall in response to exercise (Madden et al., 1995). 
Given that no differences in the response of NOx were observed in any of the exercise bouts 
(table 4.1), it appears that in this study, lymphocyte mobilisation was related to adrenaline 
release.  
In conclusion, this study presents evidence to suggest that a bout of LV-HIIT does not 
stimulate a significantly different response in markers of oxidative stress to the responses 
seen following short duration high or moderate intensity steady state exercise. When 
considering other physiological markers (i.e. heart rate, adrenaline and lymphocytosis), 
HIGH was the greatest stressor, with LV-HIIT being more comparable to MOD. When 
assessing the anti-inflammatory response to exercise, LV-HIIT was more comparable to 
HIGH.  
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Chapter Five 
5. Thioredoxin and over-oxidised peroxiredoxin are increased 
in peripheral blood mononuclear cells during exercise in 
humans 
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5.1. Abstract 
Introduction: Peroxiredoxin (PRDX) and Thioredoxin (TRX) are antioxidant proteins that 
control cellular signalling and redox balance, and are also associated with heightened 
inflammation. This study aimed to assess key aspects of the PRDX-TRX redox cycle in 
response to three different modes of exercise. 
Methods: Healthy males (n=10, mean ± SD: age 22 ± 3 yrs) undertook three exercise trials 
on separate days: two steady-state cycling trials at a moderate (60% VO2MAX; 27 min, MOD) 
and high (80% VO2MAX; 20 min, HIGH) intensity, and a low volume high intensity interval 
training trial (10*1 min 90% VO2MAX, LV-HIIT). Peripheral blood mononuclear cells were 
assessed for TRX reductase (TRX-R) activity, TRX-1 and over-oxidised PRDX (isoforms I-
IV) protein expression and plasma for interleukins (IL)-6 and IL-10 before, during and 30 
minutes following exercise (post+30). 
Results: TRX-1 protein expression increased during exercise in all trials (MOD +84.5%; 
HIGH +64.1%; LV-HIIT +205.7%; p<.05), whereas over-oxidised PRDX increased during 
HIGH only (MOD -28.7%; HIGH +202.9%; LV-HIIT -22.7%; p<.05). TRX-R activity 
increased during exercise in all trials, with the greatest response seen in HIGH (p<.05). IL-6 
and IL-10 increased during exercise and post+30, and post+30 only respectively in HIGH and 
LV-HIIT (p<.05). 
Discussion: All exercise trials stimulated an increase in TRX-1 protein expression and TRX-
R activity. PRDX over-oxidation increased in HIGH only, suggesting that the capacity for 
TRX to recycle over-oxidised PRDX was reduced compared to MOD and LV-HIIT. Over-
oxidation of PRDX was associated with increases in IL-6, adding support for the links 
between redox proteins and inflammation. 
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5.2. Introduction 
Exercise induces the production of reactive oxygen and nitrogen species (RONS), which 
act as important signalling molecules in the vast array of metabolic adaptations that take 
place in human tissues (Gomez-Cabrera et al., 2008; Radak et al., 2005). However, some 
exercise modes and intensities are also associated with acute increases in cellular oxidative 
stress, a state whereby RONS overwhelm endogenous antioxidant defence systems (Turner et 
al., 2011; Sureda et al., 2005). The exercise conditions required to achieve an optimal 
production of RONS in order to stimulate adaptive processes, versus RONS that may initiate 
damage, is currently unknown. Changes in markers of oxidative stress with exercise are 
commonly studied in peripheral blood mononuclear cells (PBMCs) (Tauler et al., 2006; 
Sureda et al., 2005) and recent work has focussed on antioxidant redox proteins such as 
Peroxiredoxin (PRDX) (Turner et al., 2013) and Thioredoxin (TRX) (Sumida et al., 2004). 
PBMCs consist of lymphocytes and monocytes that have various roles in immunity. It has 
been proposed that a lower antioxidant content within these cells could adversely affect cell 
function (Messina and Lawrence, 1989). Conversely, abnormally high TRX in PBMCs has 
been linked with the inhibition of key apoptotic pathways that control the clearance of 
inflammatory cells (Holmgren and Lu, 2010; Szabó-Taylor et al., 2012). Similarly, both 
PRDX (Shichita et al., 2012) and TRX (Maurice et al., 1999; Schenk et al., 1996) have been 
associated with heightened inflammatory cytokine production. Given that oxidative stress and 
inflammation are associated with a wide variety of metabolic, neurological and inflammatory 
diseases (Aldred, 2007), understanding how PRDX and TRX regulate the levels of RONS 
within PBMCs may be essential in aiding understanding of the adaptive and damaging roles 
of RONS in response to exercise. 
PRDX and TRX are ubiquitous oxidoreductase proteins that contain thiol groups with a 
high capacity to control cellular levels of RONS and reduce oxidative stress (Schenk et al., 
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1994; Wood et al., 2003). PRDX directly targets and reduces biological peroxides such as 
hydrogen peroxide, peroxynitrite and hydroperoxides (Wood et al., 2003) to regulate cellular 
signalling within lipid rafts (Rhee et al., 2012). TRX is central in maintaining the reduced 
state of various antioxidant peroxidase enzymes (Burke-Gaffney et al., 2005), including four 
isoforms (I-IV) of PRDX (Peskin et al., 2007; Kang, 1998). In addition, there is evidence that 
TRX can directly scavenge hydrogen peroxide (Kang, 1998). 
Due to their role in controlling levels of RONS, the oxidation states of TRX and PRDX 
have been studied extensively to facilitate the understanding of cellular signalling in health 
and disease. The catalytic cysteine of monomeric PRDX (20-30 kDa) can become oxidised 
by a peroxidase substrate to form sulfenic acid, before rapidly reacting with an adjacent 
PRDX molecule to form a dimeric structure (chapter one, figure 1.4). PRDX (isoforms I-IV) 
redox cycles are known to be predominantly regulated by the TRX redox cycle (Peskin et al., 
2007; Rhee et al., 2005). TRX exists in two distinct states; a reduced state (12-14 kDa), with 
exposed thiol groups, or an oxidised state (≈62-64kDa), whereby the thiol groups join to form 
a disulphide bond that inhibits the antioxidant function of TRX (Zhou et al., 2010; Spindel et 
al., 2011). Under conditions of high peroxide exposure, PRDX has the capacity to become 
over–oxidised (Rhee et al., 2007), and exceed the regulatory control of TRX (Low et al., 
2008). Over-oxidation of PRDX forms sulfinic and sulfonic acid PRDX oxidation states 
(PRDX-SO2-3) that have limited or no peroxidase activity respectively (Brinkmann and 
Brixius, 2013).  
Only one study has previously addressed exercise induced changes to PBMC PRDX 
oxidation states in humans (Turner et al., 2013). Turner et al, (2013) observed an increase in 
PRDX protein expression and oxidation immediately following an ultra-endurance race 
(126.7 - 233.4km; 20.4 - 41.4 hours of continuous running) in middle aged men. These data 
indicated an environment of oxidative stress. The role of TRX in this redox cycle has not 
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been previously monitored. The only study that has assessed TRX in humans reported an 
increase in plasma TRX in response to an ultra-endurance race (Marumoto et al., 2010).  
To our knowledge no studies have monitored the over-oxidation of PBMC PRDX 
isoforms (I-IV) and their associations with TRX and inflammation in response to modes of 
exercise that are more commonly undertaken (i.e. <30 minutes). Further, no studies have 
examined the impact of exercise intensity on these redox processes. The aim of the present 
study was to investigate PRDX-1 and TRX-1 protein expression, TRX reductase enzyme 
activity and the degree of PRDX over-oxidation of PBMCs in response to three short duration 
exercise trials. In addition, systemic changes in plasma interleukins (IL)-6 and IL-10 were 
measured. 
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5.3. Methods 
5.3.1. Participants 
 Ten healthy males (mean ± SD: age 22 ± 3 yrs; VO2MAX 42.7 ± 5.0 ml/kg/min-1) 
undertook three exercise trials, each separated by at least seven days (figure 5.1). All 
participants gave their informed written consent and the study was approved by the Science 
and Technology Ethical Review Committee at the University of Birmingham. No participants 
had taken any vitamin supplements or anti-inflammatory drugs for fourteen days prior to the 
first laboratory visit. Subjects were also required to refrain from any strenuous physical 
activity, consumption of alcoholic beverages or food or drink with high nitrate content 
(beetroot, lettuce, spinach and processed meats) for at least two days prior to each 
experimental session. 
 
5.3.2. Preliminary Assessments 
 All experimental sessions took place in School of Sport, Exercise and Rehabilitation 
Sciences at the University of Birmingham. Participants visited the laboratory to complete 
questionnaires addressing health history and demographics, and to have height and weight 
assessed (Seca Alpha, Hamburg, Germany). Cardiorespiratory fitness (VO2MAX) was 
measured using an incremental test to exhaustion on an electromagnetically braked cycle 
ergometer (Lode Excalibur Sport, Groningen, Netherlands). Following a three-minute warm 
up at 30 watts, workload was increased by 30 watts every minute, until volitional exhaustion. 
Oxygen uptake was assessed continuously using a breath-by-breath system (Oxygon Prx, 
Jaeger, Wuerzberg, Germany) and heart rate monitored using a Polar Vantage heart rate 
monitor (Polar Vantage, Kempele, Finland). The following criteria were used to indicate that 
VO2MAX had been reached: a fall in cadence below 60rpm, a respiratory exchange ratio 
(VCO2/VO2) >1.10-1.15, plateau in participant oxygen consumption or a maximal heart 
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rate >220 beats min-1- age (Howley et al., 1995). VO2MAX was expressed relative to body 
weight (ml.kg-1min-1). 
 
5.3.3. Exercise Trials 
 Seven days after preliminary measurements, participants returned to the laboratory 
following an overnight fast to undertake one of three exercise trials, separated by at least 
seven days, in a randomised design. Prior to each exercise trial, subjects undertook a warm up 
(5 minutes) at a workload eliciting 40% VO2MAX. Exercise trials were: two workload 
matched steady-state cycling trials at moderate (60% VO2MAX; 27 minutes, MOD) and high 
(80% VO2MAX; 20 minutes, HIGH) intensity and a low volume high intensity interval training 
(LV-HIIT) trial. LV-HIIT consisted of ten 1 minute cycling intervals at 90% VO2MAX, with 1 
minute low intensity cycling at 40% VO2MAX (figure 5.1).  
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Figure 5.1:  Experimental protocol. Subjects completed an exercise test to exhaustion and 
then participated in 3 subsequent exercise trials.  LV-HIIT consisted of ten 1 minute stages at 
90% VO2MAX, interspersed with nine 1 minute intervals at 40% VO2MAX.  
↓ Blood samples (baseline, exercise & post+30);   R, Rest;   W, Warm up 
 
5.3.4. Blood sampling 
Prior to exercise, a catheter (Becton, Dickson & Company, Oxford, UK) was inserted 
into the antecubital vein of the arm and a rested blood sample drawn after thirty minutes of 
supine rest (baseline). The catheter was kept patent with saline (0.9% NaCl). Subsequent 
blood samples were taken during the last minute of exercise (exercise) and then 30 minutes 
following the exercise trial (post+30). At each time point, 20 ml of blood was drawn into four 
separate vacutainer tubes containing potassium ethylene diaminetetraacetic acid (EDTA) 
(Becton, Dickson & Company, Oxford, UK). Blood (5 ml) was then centrifuged at 2800 rpm 
for 15 minutes at 4 °C, plasma extracted and stored at -80 °C until further analyses. 
 
5.3.5. Blood Cell Isolation 
Three EDTA tubes (approximately 15 ml) from each time point were used to isolate 
PBMCs from whole blood using density gradient centrifugation.  Briefly, whole blood was 
diluted 1:1 with Roswell Park Memorial Institute Media (RMPI), and then layered carefully 
on top of Ficoll paque PLUS (GE Healthcare) (2:1), before centrifuging at 1,350g for 30 
minutes at 21°C.  The PBMC layer was aspirated and then washed three times with RPMI, by 
centrifuging steps at 1600rpm for 5 minutes.. The final cell pellet was divided into two equal 
aliquots. The first aliquot was lysed using RIPA buffer (1x, Sigma Aldrich) containing a 
protease inhibitor cocktail (1µl/ml, Sigma Aldrich), vortexed thoroughly and lysate collected. 
The second aliquot was resuspended in a freezing mixture (RPMI, fetal calf serum (FCS) and 
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dimethyl sulfoxide (DMSO); 7:2:1) and frozen at −1°C /min using a freezing container 
(Nalgene “Mr Frosty” Thermoscientific). Both aliquots were stored at -80°C until further 
analyses. 
 
5.3.6. Analytical Procedures 
 Whole blood cell counts (i.e., total leukocyte differential) were assessed using the 
coulter principle (Coulter Analyser, Beckman-Coulter, High Wycombe, UK). Haemoglobin 
(g/dL) and haematocrit (%) were assessed to calculate plasma volume changes as a result of 
exercise (Kargotich et al., 1997). Protein concentration was determined using the 
bicinchoninic assay method (Smith et al., 1985). 
 
Validation of PRDX-SO2-3 (I-IV) Antibody: oxidation of PRDX-1 
The PRDX-SO2-3 (I-IV) antibody was validated using a recombinant PRDX-1 protein 
(ab79945, Abcam, Cambridge, UK). PRDX was oxidised using peroxynitrite (Packer and 
Murphy, 1994). Solutions of hydrogen peroxide (0.6 M HCl and 0.7 M hydrogen peroxide) 
and sodium nitrite (0.6M) were thoroughly mixed (5 minutes) and added to rapidly stirring 
sodium hydroxide (2 M) to arrest the reaction. Four separate oxidising solutions were made 
(0, 35, 70, 140 mM peroxynitrite) and mixed 1:1 with PRDX-1 recombinant protein (1.25 µg). 
PRDX samples were incubated for one hour at 37 °C. Western blotting was carried out as 
below to assess the amount of PRDX-1 and PRDX-SO2-3 (I-IV). 
 
Western Blotting Protocol 
All reagent mixtures were sonicated thoroughly prior to use. Standards (PRDX-1 
protein (peroxynitrite: 0-140 mM), 1.25 µg) and PBMC protein lysates (10 µg) were mixed 
1:1 with laemmli sample buffer (10% 2-mercaptoethanol, Sigma Aldrich, Dorset, UK) and 
 
 
141 
 
separated on 15-18% polyacrylamide gels. Gels were electrophoresed at 115V for 105 
minutes using electrophoresis buffer (25 mM Tris, 192 mM glycine, and 0.1% w/v SDS). 
Proteins were transferred onto Hybond-P® PVDF membrane (GE Healthcare, Amersham, 
UK) with transfer buffer (25 mM Tris, 192 mM glycine, and 20% w/v methanol) for 105 
minutes at 170mA. Transfer was assessed by Ponceau S (Sigma Aldrich, Dorset, UK) before 
membranes were washed with sodium hydroxide (0.1 M) and then blocked overnight in non-
fat milk (5%) in TBST blocking buffer (0.21 M NaCl, 0.05 M Tris Base, 0.1% w/v tween). 
Membranes were washed 6 times (5 minutes) in TBST (0.21 M NaCl, 0.05 M Tris Base, 0.05% 
w/v tween-20) prior to incubation with rabbit polyclonal for anti-PRDX-SO2-3 (I-IV) (1:500, 
ab16830), rabbit polyclonal anti-PRDX-1 (1:1000, ab15571), mouse monoclonal anti-TRX-1 
(1:1000, ab16965, Abcam, Cambridge, UK), and mouse monoclonal anti-actin (1:10,000, 
Sigma Aldrich, Dorset, UK) antibodies for 2 hours at room temperature. Membranes were 
washed (6x5 min) before peroxidase conjugated goat anti-rabbit (for PRDX and PRDX SO2-3 
(I-IV) work, 1:10,000, A6154) or goat anti-mouse (for TRX-1 and actin work, 1:10,000, 
A0168) antibodies (Sigma Aldrich, Dorset, UK) were applied for 1 hour at room temperature. 
Following a further washing step (6 x 5 min), visualisation of proteins was undertaken using 
Amersham ECL Prime detection reagent (GE Healthcare, Amersham, UK). Imaging and 
band quantification was assessed using Syngene G:Box F3 (Geneflow, Staffordshire, UK) and 
Syngene tools software respectively, and expressed in arbitrary units. 
 
Thioredoxin Reductase Activity 
PBMCs were rapidly thawed in a water bath (37°C). Pellets were washed twice in 
RPMI and FCS (9:1) to discard excess DMSO. Approximately 2 million cells were counted 
using a haemocytometer and aliquoted for each time point (baseline, exercise and post+30). 
All samples were adjusted to the lowest sample protein concentration. The lysate was then 
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assessed for TRX reductase enzyme activity using a commercially available kit according to 
manufacturer instructions (ab83463, Abcam, Cambridge, UK). Briefly, assay buffer (10 µl) or 
TRX reductase inhibitor (10 µl) were added to two sets of identical samples (50 µl, diluted to 
0.55mg/ml protein using assay buffer). All samples were then incubated with a reaction mix 
(30µl assay buffer + 8µl 5,5’-dithiobis (2-nitrobenzoic) acid (DNTB) + 2ul nicotinamide 
adenine dinucleotide phosphate (NADH) per well) and absorbances (λ = 412 nm) determined 
immediately and at 25 minutes to monitor reaction kinetics (Labsystems Multiskan MS, 
Virginia, USA). Values were then obtained from a linear standard curve of known 5-thio-2-
nitrobenzoic acid (TNB) concentrations (0-50 nmol/well). 
 
Interleukins 
Plasma concentrations of IL-6 and IL-10 were determined using commercially 
available high-Sensitivity ELISA kits according to manufacturer instructions (R&D Systems, 
Oxfordshire). Briefly, samples (200 µl, diluted 1:1 with assay diluent) were incubated with a 
monoclonal antibody (200 µl) derived against IL-6, and then substrate (50 µl) and amplifier 
(50 µl) solutions added to develop the colour change. Plates were washed in-between stages 
to reduce non-specific binding. The reaction was stopped using 2 M sulphuric acid (50 µl) 
and absorbance’s read at 650 nm. Values were then obtained from a linear standard curve 
(0.156-10  pg/ml IL-6) and adjusted for changes in plasma volume (Kargotich et al., 1997).  
 To determine IL-10 concentrations, samples (250 µl, diluted 4:1 with assay diluent) 
were incubated with a monoclonal antibody (200 µl) derived against IL-10 and then substrate 
(50 µl) and amplifier (50 µl) solutions added to develop a colour change. Plates were washed 
intermittently to reduce non-specific binding. The reaction was stopped using 2 M sulphuric 
acid (50 µl) and absorbance read at 490 nm. Values were then obtained from a linear standard 
curve of known IL-10 concentrations (0.78-50 pg/ml) and adjusted for plasma volume. 
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5.3.11. Statistical Analysis 
 Statistical analyses were performed using SPSS (PASW Statistics, release 21.0, SPSS 
Inc., Chicago, IL, USA).  Differences between variables at baseline were assessed using one-
way analyses of variance (ANOVA). The Kolmogorov Smirnov test was used to test for 
normally distributed data at all time points. Changes to the oxidation of recombinant PRDX 
protein (antibody validation) were assessed by paired samples t-tests. TRX-1 and PRDX-SO3 
protein expression changes in response to exercise were analysed using the Friedman’s test, 
with Wilcoxon signed-ranked pairwise comparisons. Changes in PRDX-1 protein expression, 
TRX-R activity and inflammatory cytokines in response to exercise were assessed by 
repeated measures ANOVA. Post hoc analysis of any interaction effects was performed by a 
test of simple effects by pairwise comparisons, with Bonferroni correction. Statistical 
significance was accepted at the p<.05 level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
144 
 
5.4. Results 
5.4.1. Exercise Physiology Data 
Table 5.1 reports the average workload and energy expenditure data following the 
three exercise trials. Energy expenditure following the LV-HIIT trial was significantly lower 
than both MOD (p<0.0001) and HIGH (p<0.0001) trials. There were no statistical differences 
in energy expenditure between MOD and HIGH. 
 
 
 
 
Average 
Workload 
(Watts) 
Energy 
Expenditure 
(Kcal) 
Difference in 
EE relative to 
LV-HIIT (%) 
MOD 109.84 ± 17.89 263.61 ± 39.43* 27.75 
HIGH 169.35 ± 31.50 266.37 ± 39.30* 28.50 
LV-HIIT 210.60 ± 38.30 190.46 ± 29.83 - 
 
Table 5.1:  Exercise Physiology Data: Average workload (Watts), energy expenditure (Kcal) 
and percentage difference (%) in energy expenditure relative to LV-HIIT in the three exercise 
trials (n=10). * indicates a significant difference in energy expenditure, relative to LV-HIIT. 
 
5.4.2. White Blood Cell Data 
 Table 5.2 reports the changes in lymphocyte number, monocyte number and 
lymphocyte: monocyte ratio in response to the three exercise trials. Lymphocyte number 
increased during exercise in all trials (p<0.0001) and returned to baseline post+30 (p<.0001). 
A significant time*condition interaction was observed (p<.0001) and pairwise comparisons 
revealed that the increase in lymphocyte number during HIGH was greater than both MOD 
(p=0.002) and LV-HIIT (p=0.032). Monocyte number increased during exercise in all trials 
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(p=0.010) and returned to baseline levels post+30 (p=.004). No differences were observed in 
monocyte number between trials. No statistical differences were observed in lymphocyte: 
monocyte ratio in response to any of the exercise trials.  
 
  
Lymphocytes 
 (×106/ml) 
Monocytes 
(×106/ml) 
Lymphocyte: 
Monocyte 
Ratio 
MOD 
Baseline 1.89 ± 0.47 0.29 ± 0.15 7.60 ± 3.04 
During 2.67 ± 0.75* 0.43 ± 0.21* 7.62 ± 4.91 
Post+30 1.67 ± 0.35 0.22 ± 0.08 8.57 ± 3.51 
HIGH 
Baseline 1.86 ± 0.42 0.32 ± 0.18 7.44 ± 3.58 
During 4.63 ± 1.41*# 0.60 ± 0.40* 9.65 ± 5.06 
Post+30 1.78 ± 0.39 0.31 ± 0.14 6.76 ± 3.14 
 
LV-HIIT 
 
Baseline 1.79 ± 0.47 0.23 ± 0.11 10.02 ± 6.50 
During 3.57 ± 1.40* 0.40 ± 0.12* 10.27 ± 6.09 
Post+30 1.62 ± 0.38 0.33 ± 0.16 5.66 ± 1.98 
 
Table 5.2:  White Blood Cell Data: Lymphocyte, Monocyte and Lymphocyte: Monocyte 
Ratio data in response to exercise in the MOD, HIGH and LV-HIIT trials (n=10). * indicates 
a significant difference relative to baseline. # indicates a significantly greater response during 
HIGH relative to MOD and LV-HIIT. 
 
5.4.3. Validation of antibody: Peroxynitrite Oxidation (35-140mM)  
Figure 5.2 shows the changes in PRDX-1 protein expression and PRDX over-
oxidation following oxidation using peroxynitrite (35-140 mM), expressed in arbitrary units. 
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Figure 5.3 illustrates two example western blotting images of PRDX-SO2-3 (I-IV). PRDX-
SO2-3 (I-IV) was significantly greater following exposure with 140mM peroxynitrite, relative 
to 35mM (p=.027). Figure 5.4 illustrates a western blotting image of PRDX-1 protein 
expression following no manipulation, and oxidation using peroxynitrite (0-140mM). The 
PRDX-1 band was not detectable following oxidation with peroxynitrite, irrespective of 
concentration (p<.0001) (figure 5.2). 
 
Figure 5.2:  Changes in protein expression of PRDX-1 and PRDX-SO2 -3 in response to 
peroxynitrite exposure (n=2). * indicates significant difference in PRDX-SO2 -3 relative to 
35mM peroxynitrite (p<0.05). # indicates significant difference in PRDX relative to 0mM 
peroxynitrite (p<0.05). 
 
 
                 
 
Figure 5.3:  Two example western blots (A and B) for PRDX-SO2-3 (I-IV) following PRDX-
1 oxidation with peroxynitrite. Lane 1, PRDX-1 (1.25 µg, 35 mM peroxynitrite); Lane 2, 
PRDX-1 (1.25 µg, 70 mM peroxynitrite); Lane 3, PRDX-1 (1.25 µg, 140 mM peroxynitrite).  
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Figure 5.4:  Western blot of PRDX-1 following PRDX-1 oxidation with peroxynitrite. Lane 
1, PRDX-1 (1.25 µg): Lane 2, PRDX-1 (1.25 µg, 35 mM peroxynitrite); Lane 3, PRDX-1 
(1.25 µg, 70 mM peroxynitrite); Lane 4, PRDX-1 (1.25 µg, 140 mM peroxynitrite). 
 
5.4.4. Thioredoxin, Peroxiredoxin-1, Peroxiredoxin-SO2-3 (I-IV) and actin protein 
expression changes 
Figures 5.5 and 5.6 indicate changes in the amount of TRX-1 and PRDX SO2-3 (I-IV) 
in the three exercise trials following quantification with Genetools (arbitrary values). TRX-1 
increased in response to exercise in MOD (Ӽ2 (2) = 8.600, p=0.014), HIGH (Ӽ2 (2) = 6.200, 
p=0.045) and LV-HIIT (Ӽ2 (2) = 11.436, p=0.003). Post hoc analyses with Wilcoxon signed-
rank tests revealed a significant increase in TRX-1 from baseline to during exercise in the 
LV-HIIT trial only (Z = -2.666, p=0.008). However, no differences were observed in TRX-1 
protein expression during exercise between the three trials, i.e. increases in TRX-1 were not 
exercise intensity dependent. PRDX-1 was not detectable in any of the samples. PRDX-SO2-3 
increased in response to HIGH only (Ӽ2 (2) = 7.824, p=0.020). Post hoc analyses revealed 
that PRDX- SO2-3 increased during HIGH, relative to baseline (Z = -2.524, p=.012). No 
statistical differences were observed in actin protein expression, relative to baseline in each 
trial or between trials. 
22kDa 
35mM 70mM 0mM 140mM 
1 2 3 4 
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Figure 5.5:  Total TRX-1 levels in response to the three exercise trials (n=10). Data points 
represent total TRX-1 in PBMC lysates before (Baseline), during (Exercise) and thirty 
minutes following exercise (Post+30). Values are means ± standard error. * indicates 
significant differences during exercise, relative to baseline in all trials (p<0.05). 
MOD (             ), HIGH (            ) and LV-HIIT (            ). 
 
 
 
Figure 5.6:  Total PRDX-SO2-3 (I-IV) levels in response to the three exercise trials (n=10). 
Data points represent total PRDX-SO2-3 (I-IV)  in PBMC lysates before (Baseline), during 
(Exercise) and thirty minutes following exercise (Post+30). Values are means ± standard 
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error. ** indicates differences between values in the different trials (p<0.05). + indicates a 
significant difference between baseline and during exercise in HIGH (p<0.05). 
MOD (             ), HIGH (            ) and LV-HIIT (            ). 
 
Figure 5.7 presents an example (1 participant) of the changes in TRX-1 (Fig 5.7A), 
PRDX-SO2-3 (I-IV) (Fig 5.7B) and actin (Fig 5.7C) in response to the three exercise trials. 
                           MOD                                HIGH        LV-HIIT 
                     Baseline  Exercise  Post+30          Baseline  Exercise  Post+30          Baseline  Exercise  Post+30 
 
                         
   
 
 
Figure 5.7:  Changes in total TRX-1 (A), PRDX-SO 2-3 (I-IV) (B) and actin (C) protein 
content in participant 1 in response to the three exercise trials. The two distinct bands in 
figure 5.7B are representative of the different isoforms of PRDX. PRDX isoforms 1 and 2 
resolve at 20-22kDa, PRDX-3 at 26kDa and PRDX-4 at 31kDa (no band). 
 
5.4.5. Thioredoxin Reductase Activity 
Figure 5.8 indicates changes in Thioredoxin reductase activity from baseline to during 
exercise in the three exercise trials. Three trial by two time ANOVAs revealed that TRX 
reductase activity increased during exercise, relative to baseline in all trials (p=.002). A 
significant group x time interaction effect was found (p=0.010), and a test of simple effects 
analysis by pairwise comparisons indicated that TRX reductase enzyme activity during 
exercise was greater in HIGH than MOD (p=.042). Differences between HIGH and LV-HIIT 
did not reach statistical significance (p=.123). 
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Figure 5.8:  Changes in Thioredoxin Reductase Activity in response to the three exercise 
trials during exercise (n=10). Filled bars represent changes in Thioredoxin Reductase 
Activity in PBMC lysates from baseline to during exercise. Values are means ± standard 
error. * indicates significant changes in response to exercise, relative to baseline in all trials 
(p<0.05). # indicates a significant difference between HIGH and MOD during exercise 
(p<0.05). 
 
5.4.6. Interleukins 
Figures 5.9 (A-B) indicates changes in IL-6 (Fig 5.9A) and IL-10 (Fig 5.9B) in 
response to the three exercise trials, as assessed by three trial by three time ANOVAs. These 
results are reported in a previous paper from our group (Wadley et al, 2014). IL-6 increased 
during exercise (p=0.05) and post+30 (p=0.001) in all trials. A significant group x time 
interaction effect was found (p=0.012), and a test of simple effects analysis by pairwise 
comparisons indicated that the concentrations of IL-6 post+30 were significantly higher in 
HIGH than the MOD (p=0.037). There were increases in IL-6 during exercise (LV-HIIT: 
p=0.029; HIGH: p=0.048) and post+30 (LV-HIIT: p=0.010; HIGH: p=0.016) relative to 
baseline in the LV-HIIT and HIGH. IL-6 increased post+30, relative to baseline in MOD 
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(p=0.10). There were no statistical differences between the responses observed in LV-HIIT 
and HIGH. 
IL-10 was unchanged during exercise, however a significant increase was observed 
post+30 in HIGH and LV-HIIT trials (main effect of time: p=0.042). A significant group x 
time interaction effect was found (p=0.015), and IL-10 post+30 was greater in HIGH than 
MOD (p=0.05). IL-10 was increased post+30 relative to baseline (p=0.05) and during 
exercise (p=0.05) in LV-HIIT and HIGH respectively. There were no statistical differences in 
the IL-10 responses observed during the LV-HIIT and HIGH. 
 
Figure 5.9:  Changes in IL-6 (A) and IL-10 (B) in response to the three exercise trials. Values 
are means ± standard error. * indicates significant differences relative to baseline in all trials 
0.00
0.50
1.00
1.50
2.00
2.50
IL-6 
(pg/ml)
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
Baseline Exercise Post+30
IL-10
(pg/ml)
*
*
**
#
++
+
**
#
A 
B 
 
 
152 
 
(p<.05). ** indicates significant differences relative to during exercise in all trials. # indicates 
a significant difference between HIGH and MOD. + indicates a significant difference 
between baseline and post+30 in LV-HIIT. ++ indicates a significant difference between 
exercise and post+30 in HIGH.  
MOD (             ), HIGH (            ) and LV-HIIT (            ). 
 
5.4.7. Correlation Analysis 
A significant positive correlation was observed between the changes in PRDX-SO2-3 
(I-IV) and plasma IL-6 from baseline to during exercise in HIGH (r=.561, p=.046). No 
correlation was observed between changes in PRDX-SO2-3 (I-IV) and IL-10 from baseline to 
during exercise in HIGH (r=.266, p=.229). 
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5.5. Discussion 
This study demonstrates that PBMC TRX-1 protein content increased during exercise in 
young healthy males, irrespective of exercise intensity. An increase in over-oxidation of 
PRDX isoforms (I-IV) was shown during exercise in HIGH only. The activity of TRX-R, the 
key regulatory enzyme of both redox cycles, increased during exercise in all trials, with the 
greatest response observed in HIGH. In line with previous work linking redox proteins with 
inflammatory cytokine production, systemic IL-6 correlated with the increases in PRDX 
over-oxidation in HIGH.  
To our knowledge this is the first study assessing changes in PBMC TRX-1 protein 
content in response to single bouts of exercise in humans. Previously, TRX-1 protein 
expression in PBMCs of mice increased following 30 minutes of swimming exercise (Sumida 
et al., 2004). In response to heightened oxidative stress, cytosolic TRX-1 is released in a 
RONS-dependent manner from its binding protein Thioredoxin-interacting protein (TXNIP) 
(Zhou et al., 2010) to elicit an array of antioxidant actions. These include directly scavenge 
RONS (Kang, 1998), reducing oxidised macromolecules (Burke-Gaffney et al., 2005) and 
regulating the expression/recycling of antioxidant proteins such as manganese superoxide 
dismutase (Das, 2004) and reduced glutathione (Tan et al., 2010). The results of the current 
study and our previous work that demonstrated an increase in plasma markers of oxidative 
stress (e.g., lipid hydroperoxides and total antioxidant capacity) during all three exercise trials 
(Wadley et al., 2013), indicate a presence of both intra- and extra-cellular RONS respectively. 
It appears that exercise-induced RONS may have stimulated the release of TRX-1 from 
TXNIP (i.e. cleavage of disulphide bond), via TRX-R in all trials. Thus, we suggest that 
exercise has stimulated an antioxidant response in PBMCs during exercise.  
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Increases in PRDX over-oxidation in PBMCs during exercise likely occurs in response to 
higher levels of RONS such as hydrogen peroxide and peroxynitrite (Silveira et al., 2003). 
The catalytic cysteine residue of PRDX can utilise its peroxidase activity to regulate peroxide 
mediated cellular signalling and toxicity within lipid rafts (Wood et al., 2003) (Rhee et al., 
2012). In the current study, a significant increase in over-oxidation of PRDX was observed 
during exercise in HIGH, suggesting that peroxide exposure was highest in this trial and/or 
that TRX reductase activity was sufficient in the other trials to limit PRDX peroxidase 
activity. In addition, lower exercise-induced peroxide exposure in MOD and LV-HIIT may 
have limited PRDX cysteine oxidation to the initial oxidation state, sulfenic acid. In this 
conformational change, a PRDX cysteine residue forms a disulphide bond with an adjacent 
PRDX molecule (Rhee et al., 2005). A threshold may therefore exist, whereby exercise-
induced RONS exposure may exceed TRX-1 regulatory control and over-oxidise PRDX. This 
threshold may have been exceeded during exercise in HIGH. Given that PRDX-1 was not 
detectable in any of the samples in the current study (using a PRDX-1 antibody) and over-
oxidised PRDX-4 was also not detectable, we suggest that only PRDX isoforms II and III 
were over-oxidised during HIGH. However, it is clear that recombinant PRDX-1 is extremely 
susceptible to peroxynitrite exposure (Figure 5.4) and it must be acknowledged that the 
purchased PRDX-1 antibody may have weak affinity for PRDX-1 in isolated human cells.  
PRDX isoforms (I-IV) are known to be predominantly regulated by the TRX redox cycle 
(Peskin et al., 2007; Rhee et al., 2005), in particular the NADH dependent enzyme TRX-R. 
TRX-R activity increased during all exercise trials, with the greatest increase observed in 
HIGH. This too suggests an antioxidant response to exercise as the enzyme attempts to 
reform reduced PRDX in NADH dependent manner. 
Both TRX (Maurice et al., 1999) and PRDX (Shichita et al., 2012) have been previously 
associated with heightened inflammation. Indeed, in the current study a significant 
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correlation was observed between changes in PRDX-SO2-3(I-IV) and changes in IL-6 from 
baseline to during exercise in HIGH. Recent evidence has demonstrated that following TRX-
TXNIP dissociation, TXNIP can directly induce increases in IL-1β, an early inflammatory 
cascade cytokine (Zhou et al., 2010) and signal for IL-6 production (Lorre et al., 1994). 
Similarly, PRDX has been linked with IL-23 (Shichita et al., 2012) and IL-6 production in 
macrophages (Riddell et al., 2010) Low PRDX content in lymphocytes is associated with 
uncontrolled immune activation that may lead to subsequent cytokine production (Lorre et al., 
1994; Michalek et al., 2012). Conversely, high PRDX content in pro-inflammatory 
macrophages, that are derived from monocytes have also been associated with cytokine 
production (Boytard et al., 2013). Recent evidence has suggested that PRDX mediated 
cytokine production in pro-inflammatory macrophages is independent of the peroxidase 
activity of PRDX, but instead is related to chaperone activity (Riddell et al., 2010). This 
study does not seek to present a mechanism for the observed association between PRDX 
over-oxidation and cytokine production. It is however clear that further research is necessary 
to understand the interactions and relationships between the redox cycle of PBMCs and the 
inflammatory response/immune cell function.  
It must be noted that despite normalisation for total cell and protein content, shifts in the 
number and phenotype of lymphocytes and monocytes can occur during exercise (Tauler et 
al., 2006; Campbell et al., 2009). Indeed, lymphocyte and monocyte number did increase in 
response to exercise in all trials (table 5.2). However, previous work has indicated that shifts 
in the cellular composition of peripheral blood do not influence biomarkers of oxidative 
stress (Turner et al., 2011). Finally, a limitation to the current study is that PRDX (II-III) 
protein expression was not measured to quantify the relative oxidised to reduced ratio of 
PRDX proteins. Despite no significant differences in baseline PRDX-SO2-3(I-IV), figure 
5.7B clearly indicates baseline variation in the example participant. Recent evidence has 
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indicated that peroxiredoxin oxidation displays a circadian rhythm (Edgar et al, 2012) and 
although all exercise trials were performed at the same time of day, this data indicates how 
basal metabolism can influence redox homeostasis. 
In conclusion, the present results show that both TRX-1 and PRDX are perturbed in 
response to exercise in PBMC’s of untrained males. Whilst similar increases in TRX-1 were 
observed in response to all exercise trials, only HIGH caused over-oxidation of PRDX which 
appeared to exceed the regulatory control of TRX-R. In addition, PRDX over-oxidation 
during HIGH was associated with increases in systemic IL-6. Although the implications of 
PRDX over-oxidation in response to exercise are currently unknown, these data support links 
between oxidative stress (redox protein status changes) and inflammation in response to 
exercise. 
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Chapter Six 
6. General Discussion 
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6.1 Summary 
The work undertaken in this thesis has investigated how markers of oxidative stress 
and inflammation respond to exercise. A primarily focus was to explore some of the factors 
which might alter these responses. For example: chapters 4 and 5 investigated the impact of 
exercise intensity on the oxidative stress and inflammatory responses to acute exercise; and 
chapters 2 and 3 aimed to assess the impact of altered baseline inflammation on the oxidative 
stress response to acute exercise, exercise training and psychological stress. An overarching 
aim of this thesis was to identify associations between oxidative stress and inflammation, in 
response to exercise. Commonly assessed markers of oxidative stress (lipid peroxidation, 
protein oxidation and total antioxidant capacity) were measured throughout this thesis to 
allow comparisons between the responses of different participant groups used in the studies 
presented. 
 
6.2 Influence of exercise intensity on oxidative stress  
Chapters 4 and 5 investigated markers of oxidative stress and inflammation in 
response to exercise of different intensities. Many researchers agree that the increases 
observed in oxidative stress in response to exercise are not directly related to total workload 
(St-Pierre et al., 2002; Quindry et al., 2003; Di Meo and Venditti, 2001), but that exercise 
intensity (Bailey et al., 2004) and duration (Bloomer et al., 2007) might be more influential 
factors. Data presented in chapters 4 and 5 collectively support the hypothesis and previous 
studies (Berzosa et al., 2011; Wang and Huang, 2005), indicating that changes in selective 
markers of oxidative stress in plasma and PBMC  are exercise intensity dependent. Changes 
in mean plasma lipid oxidation were different between bouts (LOOH (nmol/ml plasma): 
moderate +0.36; high +3.09; LV-HIIT +5.51) although the difference in magnitude of 
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response did not reach statistical significance. Notably, changes in TAC were not intensity 
dependent, which supports previous work (Berzosa et al., 2011). Chapter 5 further explored 
redox specific changes in PBMCs in response to these bouts. PRDX over-oxidation was 
intensity dependent when comparing the steady state bouts, but not in LV-HIIT, supporting a 
relationship previously shown when assessing lipid oxidation in PBMCs (Wang and Huang, 
2005). PRDX may therefore utilise its antioxidant capacity to limit peroxide mediated lipid 
oxidation at higher steady state exercise intensities in PBMCs (Rhee et al., 2012). Conversely, 
TRX-1 might act to limit lipid oxidation during LV-HIIT, given that TRX-1 was elevated to 
the greatest degree in this bout (MOD +84.5%; HIGH +64.1%; LV-HIIT +205.7%; p>.05), 
without a concurrent rise in PRDX oxidation. 
Findings from chapters 4 and 5, together with supporting literature suggest that lipid 
oxidation is enhanced in response to higher exercise intensities in both plasma and PBMCs. 
This is likely to reflect increased structural remodelling of cell membranes, which might 
protect cells against future exercise bouts. Whereas changes in the oxidation state of PRDX 
may act to limit lipid oxidation at higher steady state exercise intensities, it appears that TRX 
may regulate this during LV-HIIT. This suggests that the regulation of exercise-induced 
RONS may differ depending on the modality of the exercise. This has wider implications for 
beginning to explain the surprisingly comparable adaptations that LV-HIIT coveys relative to 
steady state exercise (Rognmo et al., 2004; Wisløff et al., 2007; Hood et al., 2011). However, 
given that no direct measures of lipid oxidation or PRDX protein expression were made 
within PBMCs in chapter 5, this remains speculative. 
These studies also investigated the response of factors that influence inflammation. 
Results support previous findings that plasma IL-6 and IL-10 display an intensity dependent 
response to steady state exercise (Ostrowski et al., 2000; Fischer, 2006), and adds new data 
characterising the response to LV-HIIT. The magnitude of change in IL-6 and IL-10 in 
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response to LV-HIIT was more comparable to high, rather than moderate intensity steady 
state exercise. Given that LV-HIIT provided a far lower physiological insult (demonstrated 
by the cardiovascular and adrenaline responses) than high intensity steady state exercise, 
these data may advocate the use of LV-HIIT as an anti-inflammatory exercise modality in a 
variety of populations. 
In beginning to understand how markers of oxidative stress can be differentially 
altered at higher exercise intensities, it is important to consider how the stimulus (i.e. radical 
source) may ultimately form a specific adduct. Evidence from chapter two provides support, 
showing how two inflammatory stimuli can alter different markers of oxidative stress.   
 
6.3. The impact of inflammation on oxidative stress 
6.3.1. Acute Inflammation 
The first experimental study in this thesis employed two well characterised laboratory 
models of inducing inflammation, namely vaccination and eccentric exercise, to monitor the 
impact of altered baseline inflammation on the oxidative stress response to mental stress. The 
results showed that vaccination and eccentric exercise increased markers of inflammation and 
selective plasma markers of oxidative stress prior to the start of a mental stress task. Despite a 
significant cardiovascular and immune response to mental stress, markers of oxidative stress 
were unchanged in response to mental stress, regardless of the observed inflammatory status. 
Within the time frame examined post-stress in this study, acute changes in systemic oxidative 
stress appear to provide no insight into the mechanisms behind mental stress induced MI. 
Using experimental models in healthy individuals in this way showed that two 
different inflammatory signals (muscle damage and mild pathogen) both induced transient 
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increases in IL-6, but that the inflammatory stimulus altered different markers of plasma 
oxidative stress. Links between inflammation and oxidative stress are well accepted (Wadley 
et al., 2012; Csiszar et al., 2009; Ungvari et al., 2010), although the precise signalling 
mechanisms are not completely clear. Eccentric exercise induces muscle tissue damage that is 
followed by an influx of migrating phagocytic cells from the circulation which can release 
RONS to facilitate the breakdown of damaged muscle fibres (Pincemail et al., 1990). 
Conversely, vaccination introduces a mild pathogen to the body that the immune system acts 
to dispose of by mobilising and activating phagocytic cells, such as granulocytes (table 2.2) 
that can release RONS (Babior et al., 1973). The results show that vaccination stimulates 
significant changes in systemic protein oxidation and nitric oxide metabolism, whereas 
eccentric exercise elicits a significant antioxidant response. Interestingly, mean TAC 
concentrations increased and decreased in response to eccentric exercise and vaccination 
respectively. Differences may be explained by respiratory bursts from different white blood 
cell subsets. Indeed, shifts in peripheral blood composition were different between 
inflammatory conditions (tables 2.2 and 2.4), with a more pronounced rise in phagocytic cells 
in the circulation 6 hours following vaccination. Nevertheless, these data underpin the unique 
aspect of oxidative events following specific acute inflammatory signalling.  
 
6.3.2. Acute and Chronic Inflammation 
The second study in this thesis (chapter three) aimed to establish the impact of acute 
and chronic exercise on markers of oxidative stress in patients with RA, a condition that is 
associated with increased systemic and localised inflammation (Seven et al., 2008; Taysi et 
al., 2002; Sarban et al., 2005). In assessing oxidative stress perturbations in this population, 
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this allowed a comparison of disease associated chronic baseline inflammation with acute 
manipulations of baseline inflammation (chapter two).  
Plasma protein oxidation and metabolites of nitric oxide significantly increased in 
response to a single bout of exercise (heart rate eliciting 70% VO2MAX). Following three 
months of regular exercise training at the same intensity, patients fitness and disease activity 
score improved (assessed by VO2MAX, and DAS28) and there was a reduction in plasma free 
and bound 3-NT. Additional systemic markers of oxidative stress (PC, LOOH, TAC and 
CAT) and inflammation (IL-8 and CRP) were unchanged following exercise training. 
Evidence from this chapter refutes the hypothesis that exercise would stimulate reductions in 
basal oxidative stress over a period of aerobic exercise training. However, due to baseline 
inflammation and oxidative stress being low in these participants, this result was not so 
surprising.  
This study provides the first evidence that the response of oxidative stress to exercise 
in RA appears similar to the responses seen in healthy populations (Turner et al., 2011a; 
Bloomer et al., 2007; Aldred and Rohalu, 2011). Despite acute increases in selective markers 
of oxidative stress (i.e. protein carbonyls) following moderate intensity exercise (30-40 
minutes, 70% VO2MAX), over a period of training, basal level of oxidative stress and 
inflammation were not increased. In addition, when drawing comparisons of the markers 
employed in chapter 4 and previous work in our laboratory (Turner et al., 2011a), the acute 
oxidative stress response to exercise was not exaggerated in RA. Supporting literature has 
suggested that aerobic exercise of an intensity exceeding 85% HRMAX in patients with heart 
disease and chronic obstructive pulmonary disorder (COPD) can simulate increases in 
systemic oxidative stress that exceed those of healthy populations (Avogaro et al., 1986; 
Nishiyama et al., 1998; Van Helvoort et al., 2006). When considering the implications of 
these studies for exercise guidelines in RA, it is possible that exercising at higher intensities 
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may elicit changes in markers of oxidative stress and inflammation that surpass the increases 
observed in age-matched controls. Indeed, it must be noted that some studies have suggested 
that oxidation is greater within the exercising joint of an RA patient, compared to a control 
subject (Zhang et al, 1993). The pathophysiology of heart disease and COPD may differ 
significantly from RA and therefore direct comparisons are difficult to make. Importantly, it 
still remains far from clear the exact biological significance of the exaggerated responses 
observed in these populations.  
It must be noted that the ‘typical’ antioxidant response noted in response to exercise 
in chapters 2, 4 and 5 and supporting studies (Turner et al., 2011a; Berzosa et al., 2011) was 
not observed following moderate intensity exercise in RA patients. Given that resting TAC 
concentrations were lower in RA patients compared to the healthy participants in chapters 2 
and 4 (RA: 819.0 ± 121.1 vs. Health range: 935.2 – 1260.4µM), it might be speculated that an 
antioxidant response to exercise was prevented by a compromised antioxidant status at 
baseline. Given the accrued stress placed on the body with exercise of a continuous higher 
intensity nature (chapter 4), LV-HIIT may provide an attractive alternative in RA. However, 
considering the intensity dependent relationship of oxidative stress with exercise discussed 
previously, reduced antioxidant protection might be expected to exacerbate exercise-induced 
oxidative stress with any higher intensity exercise.  
 
6.4. Low volume high intensity interval training as tool in health and disease 
 LV-HIIT is known to initiate a diverse range of metabolic, vascular and physiological 
benefits that parallel adaptations observed following conventional steady state exercise in a 
range of populations (Rognmo et al., 2004; Wisløff et al., 2009). Results in chapters 4 and 5 
add to the growing body of support by reporting that a single bout of LV-HIIT can elicit anti-
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inflammatory and anti-oxidant effects during and following exercise. Strikingly, at a 
significantly reduced energy expenditure (≈-30%), cardiovascular (≈-32%) and adrenaline (≈-
38%) response compared to high intensity steady state exercise, LV-HIIT can stimulate 
comparable increases in IL-6, IL-10, TAC and TRX in response to exercise in young and 
healthy individuals. In the context of human disease, despite the documented health benefits 
of LV-HIIT in low-grade inflammatory diseases (Little et al., 2012; Wisløff et al., 2009), it 
remains unclear as to its effects on oxidative stress, inflammation and general health 
parameters in high grade inflammatory diseases, such as RA. 
 
6.5. Hormesis 
The recently proposed theory of exercise induced oxidative stress and hormesis 
suggests that there is a theoretical threshold whereby high levels of exercise-induced RONS 
may prevent adaptation, potentially compromising immunity and initiating tissue damage 
(Radak et al., 2005). Certain factors such as health status and the type of exercise (i.e. 
intensity) may exacerbate the exercise-induced RONS response and exceed this threshold. 
Data in this thesis provides no evidence to support the hormesis threshold concept. Results in 
chapter 3 indicate that exercise in RA causes transient increases in oxidative stress, however 
repeated bouts do not exacerbate basal oxidative stress. Exercise training in RA was also 
associated with improvements in disease activity and aerobic fitness, therefore suggesting 
that exercise was not harmful. Furthermore, results in chapters 4 and 5 indicate that transient 
increases in oxidative stress during exercise, even at high intensities, return to baseline within 
30 minutes. It must be noted that some studies do provide support for the hormesis threshold 
(Turner et al., 2013, 2011b). However, although these studies observed a depleted antioxidant 
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status up to 28 days following ultra-endurance exercise, this mode of exercise, at least in the 
general population, is far from conventional. 
 
6.6. Conclusions 
Increases in oxidative stress are well established in skeletal muscle (Khassaf et al., 2003; 
Petersen et al., 2012; Khassaf et al., 2001), plasma (Goldfarb et al., 2002; Bloomer et al., 
2005; Turner et al., 2011b) and PBMCs (Sureda et al., 2005; Tauler et al., 2006; Turner et al., 
2011a) in response to exercise in humans. The research in this thesis supports evidence that 
exercise can cause changes in systemic makers of oxidative stress both during and following 
steady state, interval-based and eccentric exercise. The work presented here adds to this 
evidence base with the following novel findings:  
1. A mental stress task did not stimulate acute increases in oxidative stress, irrespective 
of experimentally manipulated high baseline inflammation. This suggests that 
increased systemic oxidative stress is not the mechanism behind mental stress induced 
MI. 
2. Acute increases in oxidative stress following moderate intensity exercise in RA are 
transient.  Basal levels of oxidative stress and inflammation were not increased by a 
course of exercise training in a group of ‘disease stable’ RA patients. 
3. The plasma oxidative stress response to a single bout of LV-HIIT did not significantly 
differ to steady state exercise. 
4. A bout of LV-HIIT resulted in a lower energy expenditure, cardiovascular stress (i.e. 
heart rate and blood pressure) and plasma adrenaline response, but elicited a 
comparable anti-inflammatory and anti-oxidant response to high intensity steady state 
exercise. 
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5. TRX increased in peripheral blood mononuclear cells during exercise. The magnitude 
of change was greatest during the LV-HIIT bout. 
6. PRDX oxidation increased in peripheral blood mononuclear cells during high 
intensity steady state exercise. PRDX oxidation was associated with increases in 
plasma IL-6, adding support for the links between PRDX and inflammation, but in the 
context of exercise. 
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